PURE STORAGE, INC., 10-K filed on 4/7/2022
Annual Report
v3.22.1
Cover - USD ($)
$ in Billions
12 Months Ended
Feb. 06, 2022
Mar. 29, 2022
Jul. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Feb. 06, 2022    
Current Fiscal Year End Date --02-06    
Document Transition Report false    
Entity File Number 001-37570    
Entity Registrant Name Pure Storage, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 27-1069557    
Entity Address, Address Line One 650 Castro Street    
Entity Address, Address Line Two Suite 400    
Entity Address, City or Town Mountain View    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94041    
City Area Code 800    
Local Phone Number 379-7873    
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share    
Trading Symbol PSTG    
Security Exchange Name NYSE    
Entity Well-Known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 5.2
Entity Common Stock, Shares Outstanding (in shares)   298,498,932  
Documents Incorporated by Reference Portions of the registrant’s proxy statement for its 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended February 6, 2022.    
Amendment Flag false    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Central Index Key 0001474432    
v3.22.1
Audit Information
12 Months Ended
Feb. 06, 2022
Audit Information [Abstract]  
Auditor Name Deloitte & Touche LLP
Auditor Location San Jose, CA
Auditor Firm ID 34
v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Feb. 06, 2022
Jan. 31, 2021
Current assets:    
Cash and cash equivalents $ 466,199 $ 337,147
Marketable securities 947,073 916,388
Accounts receivable, net of allowance of $1,033 and $945 542,144 460,879
Inventory 38,942 46,733
Deferred commissions, current 81,589 57,183
Prepaid expenses and other current assets 116,232 89,836
Total current assets 2,192,179 1,908,166
Property and equipment, net 195,282 163,041
Operating lease right-of-use assets 111,763 134,668
Deferred commissions, non-current 164,718 130,741
Intangible assets, net 62,646 76,648
Goodwill 358,736 358,736
Restricted cash 10,544 10,544
Other assets, non-current 39,447 36,896
Total assets 3,135,315 2,819,440
Current liabilities:    
Accounts payable 70,704 67,530
Accrued compensation and benefits 205,431 160,817
Accrued expenses and other liabilities 78,511 61,754
Operating lease liabilities, current 35,098 32,231
Deferred revenue, current 562,576 438,321
Total current liabilities 952,320 760,653
Long-term debt 786,779 755,814
Operating lease liabilities, non-current 93,479 120,361
Deferred revenue, non-current 517,296 405,376
Other liabilities, non-current 31,105 27,230
Total liabilities 2,380,979 2,069,434
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Preferred stock, par value of $0.0001 per share— 20,000 shares authorized; no shares issued and outstanding 0 0
Class A and Class B common stock, par value of $0.0001 per share— 2,250,000 (Class A 2,000,000, Class B 250,000) shares authorized; 278,363 and 292,633 Class A shares issued and outstanding 29 28
Additional paid-in capital 2,470,943 2,307,580
Accumulated other comprehensive income (loss) (8,365) 7,410
Accumulated deficit (1,708,271) (1,565,012)
Total stockholders’ equity 754,336 750,006
Total liabilities and stockholders’ equity $ 3,135,315 $ 2,819,440
v3.22.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Feb. 06, 2022
Jan. 31, 2021
Accounts receivable, allowance $ 945 $ 1,033
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 20,000,000 20,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, shares authorized (in shares) 2,250,000,000 2,250,000,000
Class A common stock    
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, par value per share (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares issued (in shares) 292,632,893 278,363,000
Common stock, shares outstanding (in shares) 292,632,893 278,363,000
Class B common stock    
Common stock, shares authorized (in shares) 250,000,000 250,000,000
Common stock, par value per share (in dollars per share) $ 0.0001 $ 0.0001
v3.22.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Revenue:      
Revenue: $ 2,180,848 $ 1,684,179 $ 1,643,440
Cost of revenue:      
Total cost of revenue 708,329 535,255 509,886
Gross profit 1,472,519 1,148,924 1,133,554
Operating expenses:      
Research and development 581,935 480,467 433,662
Sales and marketing 799,001 716,014 728,022
General and administrative 189,981 182,477 163,153
Restructuring and other 0 30,999 0
Total operating expenses 1,570,917 1,409,957 1,324,837
Loss from operations (98,398) (261,033) (191,283)
Other income (expense), net (30,098) (9,127) (3,383)
Loss before provision for income taxes (128,496) (270,160) (194,666)
Provision for income taxes 14,763 11,916 6,321
Net loss $ (143,259) $ (282,076) $ (200,987)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.50) $ (1.05) $ (0.79)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.50) $ (1.05) $ (0.79)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 285,882 267,824 252,820
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 285,882 267,824 252,820
Product      
Revenue:      
Revenue: $ 1,442,338 $ 1,144,098 $ 1,238,654
Cost of revenue:      
Total cost of revenue 477,899 352,987 362,970
Subscription services      
Revenue:      
Revenue: 738,510 540,081 404,786
Cost of revenue:      
Total cost of revenue $ 230,430 $ 182,268 $ 146,916
v3.22.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Statement of Comprehensive Income [Abstract]      
Net loss $ (143,259) $ (282,076) $ (200,987)
Other comprehensive income (loss), net of tax:      
Unrealized net gains (losses) on available-for-sale securities (15,107) 3,213 6,510
Reclassification adjustment for net gains on available-for-sale securities included in net loss (668) (1,252) (723)
Change in unrealized net gains (losses) on available-for-sale securities (15,775) 1,961 5,787
Comprehensive loss $ (159,034) $ (280,115) $ (195,200)
v3.22.1
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Unvested restricted stock
Common Stock
Restricted Stock Units
Restricted Stock Units
Common Stock
Restricted Stock Units
Additional Paid-In Capital
Beginning balance (in shares) at Jan. 31, 2019   243,524              
Beginning balance at Jan. 31, 2019 $ 737,780 $ 24 $ 1,820,043 $ (338) $ (1,081,949)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares)   7,770              
Issuance of common stock upon exercise of stock options 42,931 $ 1 42,930            
Stock-based compensation expense 226,705   226,705            
Vesting of restricted stock units (in shares)               9,215  
Vesting of restricted stock units             $ 0 $ 1 $ (1)
Net issuance of restricted stock units ( in shares)           624      
Net issuance of restricted stock 0                
Tax withholding on vesting of restricted stock (10,379)   (10,379)            
Common stock issued under employee stock purchase plan (in shares)   3,743              
Common stock issued under employee stock purchase plan 43,298   43,298            
Repurchase of common stock (in shares)   (868)              
Repurchases of common stock (15,017)   (15,017)            
Other comprehensive income (loss) 5,787     5,787          
Net loss (200,987)       (200,987)        
Ending balance (in shares) at Feb. 02, 2020   264,008              
Ending balance at Feb. 02, 2020 830,118 $ 26 2,107,579 5,449 (1,282,936)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares)   9,734              
Issuance of common stock upon exercise of stock options 59,510 $ 1 59,509            
Stock-based compensation expense 242,685   242,685            
Vesting of restricted stock units (in shares)               11,241  
Vesting of restricted stock units             0 $ 1 (1)
Cancellation and forfeiture of restricted stock (in shares)           (317)      
Cancellation and forfeiture of restricted stock 0                
Tax withholding on vesting of restricted stock (in shares)   (490)              
Tax withholding on vesting of restricted stock (8,258)   (8,258)            
Common stock issued under employee stock purchase plan (in shares)   3,714              
Common stock issued under employee stock purchase plan 32,439   32,439            
Repurchase of common stock (in shares)   (9,527)              
Repurchases of common stock (135,175)   (135,175)            
Equity awards assumed in an acquisition 8,802   8,802            
Other comprehensive income (loss) 1,961     1,961          
Net loss (282,076)       (282,076)        
Ending balance (in shares) at Jan. 31, 2021   278,363              
Ending balance at Jan. 31, 2021 750,006 $ 28 2,307,580 7,410 (1,565,012)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares)   5,955              
Issuance of common stock upon exercise of stock options 48,543   48,543            
Stock-based compensation expense 289,185   289,185            
Vesting of restricted stock units (in shares)               12,955  
Vesting of restricted stock units             $ 0 $ 1 $ (1)
Cancellation and forfeiture of restricted stock (in shares)           (62)      
Cancellation and forfeiture of restricted stock 0                
Tax withholding on vesting of restricted stock (in shares)   (454)              
Tax withholding on vesting of restricted stock (10,835)   (10,835)            
Common stock issued under employee stock purchase plan (in shares)   4,365              
Common stock issued under employee stock purchase plan 36,641   36,641            
Repurchase of common stock (in shares)   (8,489)              
Repurchases of common stock (200,170)   (200,170)            
Other comprehensive income (loss) (15,775)     (15,775)          
Net loss (143,259)       (143,259)        
Ending balance (in shares) at Feb. 06, 2022   292,633              
Ending balance at Feb. 06, 2022 $ 754,336 $ 29 $ 2,470,943 $ (8,365) $ (1,708,271)        
v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (143,259) $ (282,076) $ (200,987)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 83,151 70,042 89,710
Amortization of debt discount and debt issuance costs 31,577 29,070 27,179
Stock-based compensation expense 286,963 242,344 226,705
Impairment of long-lived assets 471 7,505 0
Other 13,075 7,340 1,336
Changes in operating assets and liabilities, net of effects of acquisitions:      
Accounts receivable, net (81,247) 410 (79,442)
Inventory 4,118 (8,690) 2,393
Deferred commissions (58,383) (48,721) (24,231)
Prepaid expenses and other assets (25,788) (33,982) (16,734)
Operating lease right-of-use assets 29,952 28,804 26,511
Accounts payable 6,711 (14,364) (18,856)
Accrued compensation and other liabilities 58,961 76,972 20,296
Operating lease liabilities (32,351) (27,318) (25,377)
Deferred revenue 236,176 140,305 161,071
Net cash provided by operating activities 410,127 187,641 189,574
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchases of property and equipment (102,287) (94,975) (87,847)
Acquisitions, net of cash acquired 0 (339,641) (51,594)
Purchase of intangible assets 0 0 (9,000)
Purchases of marketable securities (617,043) (573,959) (795,580)
Sales of marketable securities 200,482 171,530 200,251
Maturities of marketable securities 366,165 423,936 419,059
Other (600) (5,000) 0
Net cash used in investing activities (153,283) (418,109) (324,711)
CASH FLOWS FROM FINANCING ACTIVITIES      
Net proceeds from exercise of stock options 48,709 59,339 42,899
Proceeds from issuance of common stock under employee stock purchase plan 36,641 32,439 43,298
Proceeds from borrowings, net of issuance costs 0 251,892 0
Principal payments on borrowing and finance lease obligations (2,137) 0 0
Repayment of debt assumed from acquisition 0 0 (11,555)
Tax withholding on vesting of equity awards (10,835) (8,258) (10,379)
Repurchases of common stock (200,170) (135,175) (15,017)
Net cash provided by (used in) financing activities (127,792) 200,237 49,246
Net (decrease) increase in cash, cash equivalents and restricted cash 129,052 (30,231) (85,891)
Cash, cash equivalents and restricted cash, beginning of year 347,691 377,922 463,813
Cash, cash equivalents and restricted cash, end of year 476,743 347,691 377,922
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF YEAR      
Cash and cash equivalents 337,147 362,635  
Restricted cash 10,544 10,544 15,287
Cash, cash equivalents and restricted cash, end of year 476,743 347,691 377,922
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION      
Cash paid for interest 5,019 2,279 718
Cash paid for income taxes 12,662 10,522 4,824
Cash paid for amounts included in the measurement of operating lease liabilities 36,648 36,980 32,785
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION      
Property and equipment purchased but not yet paid 7,441 10,979 6,814
Operating lease right-of-use assets obtained in exchange for operating lease liabilities 7,517 57,471 14,937
Fair value of equity awards assumed in an acquisition $ 0 $ 8,802 $ 0
v3.22.1
Business Overview
12 Months Ended
Feb. 06, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business Overview Business Overview
Organization and Description of Business
Pure Storage, Inc. (the Company, we, us, or other similar pronouns) was originally incorporated in the state of Delaware in October 2009 under the name OS76, Inc. In January 2010, we changed our name to Pure Storage, Inc. We are headquartered in Mountain View, California and have wholly owned subsidiaries throughout the world.
v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies
12 Months Ended
Feb. 06, 2022
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
We operate using a 52/53 week fiscal year ending on the first Sunday after January 30. Fiscal 2020 and 2021 were both 52-week years that ended on February 2, 2020 and January 31, 2021, respectively. Fiscal 2022 was a 53-week year that ended on February 6, 2022. Unless otherwise stated, all dates refer to our fiscal years.
The consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries and have been prepared in conformity with accounting principles generally accepted in the United States (U.S. GAAP). All intercompany balances and transactions have been eliminated in consolidation.
Foreign Currency
The functional currency of our foreign subsidiaries is the U.S. dollar. Transactions denominated in currencies other than the functional currency are remeasured to the functional currency at the average exchange rate in effect during the period. At the end of each reporting period, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Foreign currency transaction gains and losses are recorded in other income (expense), net in the consolidated statements of operations.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Actual results could differ from these estimates and assumptions due to risks and uncertainties. Such estimates include, but are not limited to, the determination of standalone selling price for revenue arrangements with multiple performance obligations when the price at which the performance obligation sold separately or observable past transactions are not available, useful lives of intangible assets and property and equipment, the period of benefit for deferred contract costs for commissions, stock-based compensation, provision for income taxes including related reserves, fair value of equity assumed, intangible and tangible assets acquired and liabilities assumed for business combinations. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Concentration Risk
Financial instruments that are exposed to concentration of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. At the end of fiscal 2021 and 2022, the majority of our cash and cash equivalents have been invested with three financial institutions and such deposits exceed federally insured limits. Management believes that the financial institutions that hold our cash and cash equivalents and marketable securities are financially sound and, accordingly, are subject to minimal credit risk.
We define a customer as an entity that purchases our products and services from one of our channel partners or from us directly. A substantial amount of our revenue and accounts receivable are derived from the United States across a multitude of industries. We perform ongoing evaluations to determine partner and customer credit.
One customer represented 10 percent or more of total accounts receivable at the end of fiscal 2021. Also, one channel partner represented more than 10 percent or more of total accounts receivable at the end of fiscal 2022. No channel partner or customer represented more than 10 percent of revenue for fiscal 2020, 2021 or 2022.
We rely on a limited number of contract manufacturers and suppliers of components for our products. In instances where contract manufacturers and suppliers fail to perform their obligations, we may be unable to find alternative contract manufacturers and suppliers or satisfactorily deliver our products to our customers on time.
Cash and Cash Equivalents
Cash and cash equivalents consist of cash in banks and highly liquid investments, primarily money market accounts, purchased with an original maturity of three months or less.
Marketable Securities
We classify our marketable securities as available-for-sale (AFS) at the time of purchase and reevaluate such classification at each balance sheet date. We may sell these securities at any time for use in current operations even if they have not yet reached maturity. As a result, we classify our securities, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. We carry these securities at estimated fair value and record unrealized gains and losses in accumulated other comprehensive income (loss), which is reflected as a component of stockholders' equity. We evaluate our AFS debt securities with an unamortized cost basis in excess of estimated fair value to determine what amount of that difference, if any, is caused by expected credit losses. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized through an allowance for credit losses with changes in the allowance for credit losses recognized as a charge to other income (expense), net, in the consolidated statements of operations. Any remaining impairment is included in accumulated other comprehensive income (loss) as a component of stockholders' equity. Realized gains and losses from the sale of marketable securities are determined based on the specific identification method. Realized gains and losses are reported in other income (expense), net in the consolidated statements of operations.
Fair Value of Financial Instruments
The carrying value of our financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximates fair value.
Accounts Receivable and Allowance
Accounts receivable are recorded at the invoiced amount, and stated at realizable value, net of an allowance for doubtful accounts. Credit is extended to partners and customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable. We perform ongoing credit evaluations and maintain an allowance for doubtful accounts.
We assess the collectability of the accounts by taking into consideration the aging of our trade receivables, historical experience, and management judgment. We write off trade receivables against the allowance when management determines a balance is uncollectible and no longer actively pursues collection of the receivable.
The following table presents the changes in the allowance for doubtful accounts:
 
 Fiscal Year Ended
 202020212022
 (in thousands) 
Allowance for doubtful accounts, beginning balance$660 $542 $1,033 
Provision, net of cash received(80)496 (18)
Write-offs(38)(5)(70)
Allowance for doubtful accounts, ending balance$542 $1,033 $945 
Restricted Cash
Restricted cash is comprised of cash collateral for letters of credit related to our leases and for a vendor credit card program. At the end of fiscal 2021 and 2022, we had restricted cash of $10.5 million.
Inventory
Inventory consists of finished goods and component parts, which are purchased from contract manufacturers. Product demonstration units, which we regularly sell, are the primary component of our inventories. Inventories are stated at the lower of cost or net realizable value. Cost is determined using the specific identification method for finished goods and weighted-average method for component parts. We account for excess and obsolete inventory by reducing the carrying value to the estimated net realizable value of the inventory based upon management’s assumptions about future demand and market conditions. In addition, we record a liability for firm, non-cancelable and unconditional purchase commitments with contract manufacturers and suppliers for quantities in excess of future demand forecasts consistent with excess and obsolete inventory valuations. Inventory write-offs were insignificant for fiscal 2020, 2021 and 2022.
Property and Equipment, Net
Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the respective assets (test equipment—4 years, computer equipment and software—4 years, furniture and fixtures—7 years). Leasehold improvements are amortized over the shorter of their estimated useful lives or the remaining lease term. Depreciation commences once the asset is placed in service.
In accordance with our accounting practices, we review the estimated useful lives of our property and equipment on an ongoing basis. In the first quarter of fiscal 2021, management determined that the estimated useful lives of its test equipment and certain computer equipment and software required revision. The estimated useful lives of test equipment and certain computer equipment and software were revised to 4 years. Previously, the estimated useful lives of these assets ranged from 2 to 3 years. The change in estimated useful lives was accounted for as a change in estimate and recognized on a prospective basis effective February 3, 2020. The effect of this change in estimate resulted in a reduction to depreciation expense of $23.6 million during fiscal 2021.
Business Combinations
We allocate the purchase price to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of the assets acquired and liabilities assumed is recorded as goodwill. During the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the estimated fair value of the assets acquired and liabilities assumed, with the corresponding offset to goodwill. The results of operations of an acquired business is included in our consolidated financial statements from the date of acquisition. Acquisition-related expenses are expensed as incurred.
Goodwill
Goodwill represents the excess of the purchase price consideration over the estimated fair value of the tangible and intangible assets acquired and liabilities assumed in a business combination. Goodwill is evaluated for impairment annually in the fourth quarter of our fiscal year as a single reporting unit, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. We may elect to qualitatively assess whether it is more likely than not that the fair value of our reporting unit is less than its carrying value. If we opt not to qualitatively assess, a quantitative goodwill impairment test is performed. The quantitative test compares our reporting unit's carrying amount, including goodwill, to its fair value calculated based on our enterprise value. If the carrying amount exceeds its fair value, an impairment loss is recognized for the excess. We did not recognize any impairment of goodwill in any of the periods presented in the consolidated financial statements.
Purchased Intangible Assets
Purchased intangible assets with finite lives are stated at cost, net of accumulated amortization. We amortize our intangible assets on a straight-line basis over an estimated useful life of three to seven years.
Impairment of Long-Lived Assets
We review our long-lived assets, including property and equipment and finite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. We measure the recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If the total of the future undiscounted cash flows is less than the carrying amount of an asset, we record an impairment charge for the amount by which the carrying amount of the asset exceeds its fair market value.
Convertible Senior Notes
In accounting for the issuance of our convertible senior notes (the Notes), we separated the Notes into liability and equity components. The carrying amount of the liability component was determined by measuring the fair value of a similar liability that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was calculated by deducting the fair value of the liability component from the principal amount of the Notes as a whole. The difference between the principal amount of the Notes and the liability component (the debt discount) is amortized to interest expense in the consolidated statements of operations using the effective interest method over the term of the Notes. The equity component of the Notes is included in additional paid-in capital in the consolidated balance sheets and is not remeasured as long as it continues to meet the conditions for equity classification. In accounting for the transaction costs related to the issuance of the Notes, we allocated the total amount incurred to the liability and equity components using the same proportions as the initial carrying value of the Notes. Transaction costs attributable to the liability component were netted with the principal amount of the Notes in the consolidated balance sheets and are being amortized to interest expense in the consolidated statements of operations using the effective interest method over the term of the Notes. Transaction costs attributable to the equity component were netted with the equity component of the Notes in additional paid-in capital in the consolidated balance sheets.
Deferred Commissions
Deferred commissions consist of incremental costs paid to our sales force to obtain customer contracts. Deferred commissions related to product revenue are recognized upon transfer of control to customers and deferred commissions related to subscription services revenue are amortized over an expected useful life of six years. We determine the expected useful life based on an estimated benefit period by evaluating our technology development life cycle, expected customer relationship period and other factors. We classify deferred commissions as current and non-current on our consolidated balance sheets based on the timing of when we expect to recognize the expense. Amortization of deferred commissions is included in sales and marketing expense in the consolidated statements of operations.
Leases
We determine if an arrangement contains a lease at inception and classify leases as an operating or finance lease at commencement date. Lease liabilities are recognized at the present value of the future lease payments at commencement date. The interest rate implicit in our operating and finance leases is not readily determinable, and therefore an incremental borrowing rate is estimated to determine the present value of future payments. The estimated incremental borrowing rate factors in a hypothetical interest rate on a collateralized basis with similar terms, payments, and economic environments. The lease right-of-use (ROU) asset is determined based on the lease liability initially established and reduced for any prepaid lease payments and any lease incentives. We account for the lease and non-lease components of operating and finance lease contract consideration as a single lease component.
Certain of the operating lease agreements contain rent concession, rent escalation, and option to renew provisions. Rent concession and rent escalation provisions are considered in determining the lease cost. Lease cost under our operating leases is recognized on a straight-line basis over the lease term commencing on the date we have the right to use the leased property. For finance leases, we recognize amortization expense of the finance lease ROU asset on a straight-line basis over the shorter of its useful life or lease term and record interest expense for finance lease liabilities based on the incremental borrowing rate. We generally use the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that an extension or termination option will be exercised. Assets recognized and the short and long-term lease liabilities from finance leases are included in property and equipment, net, accrued expenses and other liabilities and other liabilities, non-current in the consolidated balance sheets.
In addition, certain of our operating lease agreements contain tenant improvement allowances from our landlords. These allowances are accounted for as lease incentives and reduce our ROU asset and lease cost over the lease term.
For short-term leases with lease term no longer than twelve months, and do not include an option to purchase the underlying asset that we are reasonably certain to exercise, we recognize rent expense in our consolidated statements of operations on a straight-line basis over the lease term and record variable lease payments as incurred.
Deferred Revenue
Deferred revenue primarily consists of amounts that have been invoiced but have not yet been recognized as revenue and performance obligations pertaining to subscription services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the consolidated balance sheet dates.
Revenue Recognition
We generate revenue from two sources: (1) product revenue which includes the sale of integrated storage hardware and embedded operating system software and (2) subscription services revenue which includes Evergreen Storage subscriptions, our unified subscription that includes Pure as-a-Service and Cloud Block Store, and Portworx. Subscription services revenue also include our professional services offerings such as installation and implementation consulting services.
We typically recognize product revenue upon transfer of control to our customers. Products are typically shipped directly by us to customers.
Our subscription services revenue is recognized ratably over the contractual term, which generally ranges from one to six years. The majority of our product solutions are sold with an Evergreen Storage subscription service agreement, which typically commences upon transfer of control of the corresponding products to our customers. Costs for subscription services are expensed when incurred. In addition, our Evergreen Storage subscription provides our customers with a new controller based upon certain contractual terms. The controller refresh represents a separate performance obligation that is included within the Evergreen Storage subscription service agreement and the allocated revenue is recognized upon shipment of the controller.
Our Evergreen Storage subscription services also include the right to receive unspecified software updates and upgrades on a when-and-if-available basis, software bug fixes, replacement parts and other services related to the underlying infrastructure, as well as access to our cloud-based management and support platform. We also sell professional services such as installation and implementation consulting services and the related revenue is recognized as services are performed.
We recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration we expect to be entitled in exchange for those goods or services. This is achieved through applying the following five-step approach:
Identification of the contract, or contracts, with a customer
Identification of the performance obligations in the contract
Determination of the transaction price
Allocation of the transaction price to the performance obligations in the contract
Recognition of revenue when, or as, we satisfy a performance obligation
When applying this five-step approach, we apply judgment in determining the customer's ability and intention to pay, which is based on a variety of factors including the customer's historical payment experience and/or published credit and financial information pertaining to the customer. To the extent a customer contract includes multiple promised goods or services, we determine whether promised goods or services should be accounted for as a separate performance obligation. The transaction price is determined based on the consideration which we will be entitled to in exchange for transferring goods or services to the customer. For contracts that contain multiple performance obligations, we allocate the transaction price to each performance obligation based on a relative standalone selling price. The standalone selling price is determined based on the price at which the performance obligation is sold separately, or if not observable through past transactions, is estimated taking into account available information such as market conditions and internally approved pricing guidelines related to performance obligations.
Warranty
We generally provide a three-year warranty on hardware and a 90-day warranty on our software embedded in the hardware. Our hardware warranty provides for parts replacement for defective components and our software warranty provides for bug fixes. Our Evergreen Storage subscription agreement provides for the same parts replacement that customers are entitled to under our warranty program, except that replacement parts are delivered according to targeted response times to minimize disruption to our customers’ critical business applications. Substantially all customers purchase Evergreen Storage subscription agreements. As such, the warranty reserve at the end of fiscal 2022 was not material.
Research and Development
Research and development costs are expensed as incurred. Research and development costs consist primarily of employee compensation and related expenses, prototype expenses, to the extent there is no alternative use for that equipment, depreciation of equipment used in research and development, third-party engineering and contractor support costs, data center and cloud services costs as well as allocated overhead costs.
Capitalized Internal-Use Software Costs
We expense costs to develop software that is externally marketed before technological feasibility is reached. We have determined that technological feasibility is reached shortly before the release of our products and as a result, the development costs incurred after the establishment of technological feasibility and before the release of those products have not been significant and accordingly, all related software development costs have been expensed as incurred.
We capitalize (i) costs incurred to develop or modify software solely for our internal use, including hosted applications used to deliver our support services, and (ii) certain implementation costs incurred in a hosting arrangement that is a service contract when the preliminary project stage is complete, management with the relevant authority authorizes and commits to the funding of the software project, and it is probable the project will be completed and used to perform the intended function. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Software development costs are capitalized to property, plant and equipment and amortized using the straight-line method over an estimated useful life of four years. Software development costs capitalized to property and equipment were $0.7 million and $7.8 million for fiscal 2021 and 2022.
Software implementation costs are capitalized to either prepaid and other current assets or other assets, non-current on our consolidated balance sheet and amortized over the terms of the associated hosting arrangements. Software implementation costs capitalized were $1.9 million and $3.5 million for fiscal 2021 and 2022. Related amortization expense for software implementation costs was $0.1 million and $0.5 million during fiscal 2021 and 2022.
Advertising Expenses
Advertising costs are expensed as incurred. Advertising expenses were $13.3 million, $8.1 million and $15.3 million for fiscal 2020, 2021 and 2022.
Stock-Based Compensation
Stock-based compensation includes expenses related to restricted stock units (RSUs), performance restricted stock units (PRSUs), restricted stock, stock options and purchase rights issued to employees under our employee stock purchase plan (ESPP). RSUs, PRSUs and restricted stock are measured at the fair market value of the underlying stock at the grant date. We determine the fair value of purchase rights issued to employees under our ESPP and our stock options under our equity plans on the date of grant utilizing the Black-Scholes option pricing model, which is impacted by the fair value of our common stock, as well as changes in assumptions regarding a number of subjective variables. These variables include the expected common stock price volatility over the term of the awards, the expected term of the awards, risk-free interest rates and expected dividend yield. 
We recognize stock-based compensation expense for stock-based awards with only service conditions on a straight-line basis over the period during which an employee is required to provide services in exchange for the award (generally the vesting period of the award). We account for forfeitures as they occur. For stock-based awards granted to employees with a performance condition, we recognize stock-based compensation expense for these awards under the accelerated attribution method over the requisite service period when management determines it is probable that the performance condition will be satisfied.
Income Taxes
We account for income taxes using the asset and liability method. Deferred income taxes are recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance to amounts that are more likely than not to be realized.
We recognize tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement.
Recent Accounting Pronouncement Not Yet Adopted
In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain convertible instruments, amends guidance on derivative scope exceptions for contracts in an entity's own equity, and modifies the guidance on diluted earnings per share (EPS) calculations as a result of these changes. The standard will be effective for us beginning February 7, 2022 and can be applied on either a fully retrospective or modified retrospective basis. We will adopt this standard in the first quarter of fiscal 2023 using the modified retrospective basis. The estimated cumulative effect of the accounting change on the Notes on February 7, 2022 will increase the carrying amount of the Notes by approximately $35.2 million, reduce accumulated deficit by approximately $98.1 million, and reduce additional paid-in capital by approximately $133.3 million. Future interest expense of the Notes will be lower as a result of adoption of this guidance and diluted net loss per share will be computed using the if-converted method for the Notes, which may be potentially dilutive.
v3.22.1
Financial Instruments
12 Months Ended
Feb. 06, 2022
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments Financial Instruments
Fair Value Measurements
We define fair value as the exchange price that would be received from sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Three levels of inputs may be used to measure fair value:
Level 1 - Observable inputs are unadjusted quoted prices in active markets for identical assets or liabilities;
Level 2 - Observable inputs are quoted prices for similar assets and liabilities in active markets or inputs other than quoted prices that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments; and
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on our own assumptions used to measure assets and liabilities at fair value and require significant management judgment or estimation.
Cash Equivalents, Marketable Securities and Restricted Cash
We measure our cash equivalents, marketable securities and restricted cash at fair value on a recurring basis. We classify our cash equivalents, marketable securities and restricted cash within Level 1 or Level 2 because they are valued using either quoted market prices or inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. Our fixed income available-for-sale securities consist of high quality, investment grade securities from diverse issuers. The valuation techniques used to measure the fair value of our marketable securities were derived from non-binding market consensus prices that are corroborated by observable market data or quoted market prices for similar instruments.
The following tables summarize our cash equivalents, marketable securities and restricted cash by significant investment categories and their classification within the fair value hierarchy at the end of fiscal 2021 and 2022 (in thousands):
 At the End of Fiscal 2021
 Amortized Cost Gross Unrealized GainsGross Unrealized LossesFair ValueCash EquivalentsMarketable SecuritiesRestricted Cash
Level 1    
Money market accounts$— $— $— $49,984 $39,440 $— $10,544 
Level 2    
U.S. government treasury notes339,253 3,241 (1)342,493 15,340 327,153 — 
U.S. government agencies56,729 516 — 57,245 — 57,245 — 
Corporate debt securities425,115 4,176 (33)429,258 — 429,258 — 
Foreign government bonds21,486 307 — 21,793 — 21,793 — 
Asset-backed securities79,924 1,015 — 80,939 — 80,939 — 
       Total $922,507 $9,255 $(34)$981,712 $54,780 $916,388 $10,544 
 At the End of Fiscal 2022
 Amortized Cost Gross Unrealized GainsGross Unrealized LossesFair ValueCash EquivalentsMarketable SecuritiesRestricted Cash
Level 1    
Money market accounts$— $— $— $29,275 $18,731 $— $10,544 
Level 2
U.S. government treasury notes336,303 512 (2,176)334,639 — 334,639 — 
U.S. government agencies49,153 49 (193)49,009 — 49,009 — 
Corporate debt securities491,728 384 (4,731)487,381 200 487,181 — 
Foreign government bonds12,333 37 (17)12,353 — 12,353 — 
Asset-backed securities60,361 111 (453)60,019 — 60,019 — 
Municipal bonds$3,950 $— $(78)$3,872 3,872 — 
Total$953,828 $1,093 $(7,648)$976,548 $18,931 $947,073 $10,544 
The amortized cost and estimated fair value of our marketable securities are shown below by contractual maturity (in thousands):
At the End of Fiscal 2022
 Amortized CostFair Value
Due within one year$373,547 $374,017 
Due in one to five years576,151 569,216 
Due in five to ten years3,930 3,840 
  Total$953,628 $947,073 

Unrealized losses on our debt securities have not been recorded into income because we do not intend to sell nor is it more likely than not that we will be required to sell these investments prior to recovery of their amortized cost basis. The decline in fair value of our debt securities is largely due to changes in credit spreads as a result of market conditions. The credit ratings associated with our debt securities are mostly unchanged, are highly rated and the issuers continue to make timely principal and interest payments. As a result, there were no credit or non-credit impairment charges recorded in fiscal 2020, 2021, and 2022. The following table presents gross unrealized losses and fair values for those investments that were in a continuous unrealized loss position at the end of fiscal 2021 and 2022, aggregated by investment category (in thousands):

At the End of Fiscal 2021
Less than 12 monthsGreater than 12 monthsTotal
Fair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized Loss
U.S. government treasury notes$8,301 $(1)$— $— $8,301 $(1)
Corporate debt securities32,996 (33)— — 32,996 (33)
Total$41,297 $(34)$— $— $41,297 $(34)
At the End of Fiscal 2022
Less than 12 monthsGreater than 12 monthsTotal
 Fair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized Loss
U.S. government treasury notes$193,359 $(2,176)$— $— $193,359 $(2,176)
U.S. government agencies24,388 (193)— — 24,388 (193)
Corporate debt securities 374,223 (4,708)1,182 (23)375,405 (4,731)
Foreign government bonds4,098 (17)— — 4,098 (17)
Asset-backed securities37,608 (453)— — 37,608 (453)
Municipal bonds3,872 (78)— — 3,872 (78)
     Total$637,548 $(7,625)$1,182 $(23)$638,730 $(7,648)

Realized gains or losses on sale of marketable securities were not significant for all periods presented.
Other Financial Instruments
We measure the fair value of our Notes on a quarterly basis and we determined the fair value of the Notes at the end of fiscal 2021 and 2022 to be a Level 2 measurement due to its limited trading activity. Refer to Note 7 for the net carrying amounts and estimated fair value of the Notes at the end of fiscal 2021 and 2022.
v3.22.1
Business Combinations
12 Months Ended
Feb. 06, 2022
Business Combination and Asset Acquisition [Abstract]  
Business Combinations Business Combinations
Fiscal 2021 - Acquisition of Portworx Inc.
In October 2020, we acquired all outstanding stock of Portworx Inc. (Portworx), a privately-held container storage company that provides a Kubernetes data services platform for cloud native applications. The transaction costs associated with the acquisition were not material and expensed as incurred. The total purchase consideration for the acquisition of Portworx was $352.9 million, which consisted of the following (in thousands):
Cash$344,049 
Fair value of options assumed8,802 
Total$352,851 
We assumed certain unvested and outstanding stock options for Portworx's common stock. These stock options were converted into 1.9 million stock options for shares of our common stock. The fair value of the exchanged options determined using the Black-Scholes option pricing model was $26.8 million, of which $8.8 million attributable to services performed prior to the acquisition date was allocated to purchase consideration. The remaining fair value of $18.0 million was allocated to future services and is being expensed over the remaining service periods as stock-based compensation expense. In addition, we assumed 2.0 million RSUs outstanding with a fair value of $31.8 million that is being recognized as stock-based compensation expense over a four year vesting period.
The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of the acquisition (in thousands):
AmountEstimated Useful Life
Goodwill$321,152 
Identified intangible assets:
Developed technology21,273 5 years
Customer relationships6,459 7 years
Trade name3,623 3 years
Cash4,407 
Net liabilities assumed(4,063)
Total$352,851 
Goodwill generated from this acquisition was primarily attributable to the assembled workforce and expected post-acquisition synergies from combining Portworx container data services with our data services platform to expand our capabilities to support Kubernetes and containers. Goodwill was not deductible for tax purposes. The fair values of developed technology, customer relationships and trade name were derived by applying the excess earnings method, with-and-without method, and the relief-from-royalty method, respectively, all of which are under the income approach whose underlying inputs are considered Level 3. The fair values assigned to assets acquired and liabilities assumed were based on management's estimates and assumptions.
In connection with the Portworx acquisition, we recorded a net deferred tax asset of $14.7 million. However, this amount was offset by a valuation allowance, thus, resulting in a net zero deferred tax asset during fiscal 2021. We continue to maintain a valuation allowance for our U.S. federal and state deferred tax assets.
In addition, cash payments to certain former shareholders of Portworx totaling $32.2 million are being made over three years subject to continuous employment and are recognized as an operating expense. The remaining unpaid amount was $13.5 million at the end of fiscal 2022.
The results of Portworx have been included in our consolidated statements of operations since the acquisition date and are not material. Pro forma results of operations have not been presented because the acquisition was not material to our results of operations.
Fiscal 2020 - Acquisition of Compuverde AB
In April 2019, we acquired Compuverde AB (Compuverde), a privately-held developer of file software solutions for enterprises and cloud providers based in Sweden. Acquisition-related costs were not material and expensed as incurred.
The purchase consideration was $47.9 million in cash (net of cash acquired) after repayment of $11.6 million of debt assumed. The purchase price was allocated as follows: $38.4 million in developed technology which is being amortized over seven years, $26.6 million of goodwill, $11.7 million in net liabilities assumed, and $5.4 million in deferred tax liability. The deferred tax liability was primarily a result of the difference in the book basis and tax basis related to the developed technology. Goodwill was primarily attributable to the assembled workforce and synergies from integrating Compuverde's technology with our data platform to expand our file capabilities and was not deductible for tax purposes.
In addition, cash payments to former shareholders of Compuverde totaling $15.9 million were made over a two-year period that ended during fiscal 2022 and recognized as operating expense.
Restricted stock units in the amount of $3.0 million were issued to Compuverde employees in June 2019, subject to continuous employment and are being recognized as stock-based compensation over the related vesting period.
The results of Compuverde have been included in our consolidated statements of operations since the acquisition date and are not material. Pro forma results of operations have not been presented because the acquisition was not material to our results of operations.
v3.22.1
Balance Sheet Components
12 Months Ended
Feb. 06, 2022
Balance Sheet Components Disclosure [Abstract]  
Balance Sheet Components Balance Sheet Components
Inventory
Inventory consists of the following (in thousands):
At the End of Fiscal
20212022
Raw materials$4,991 $15,734 
Finished goods41,742 23,208 
Inventory$46,733 $38,942 
Property and Equipment, Net
Property and equipment, net consists of the following (in thousands):
 At the End of Fiscal
 20212022
Test equipment$238,069 $266,672 
Computer equipment and software183,763 206,053 
Furniture and fixtures8,484 8,652 
Leasehold improvements44,444 47,443 
Capitalized software development costs755 8,528 
Total property and equipment475,515 537,348 
Less: accumulated depreciation and amortization(312,474)(342,066)
Property and equipment, net$163,041 $195,282 
Depreciation and amortization expense related to property and equipment was $80.4 million, $57.1 million and $65.9 million for fiscal 2020, 2021 and 2022, respectively.
Intangible Assets, Net
Intangible assets, net consist of the following (in thousands):
 
At the End of Fiscal
 20212022
 Gross Carrying ValueAccumulated AmortizationNet Carrying AmountGross Carrying ValueAccumulated AmortizationNet Carrying Amount
Technology patents$19,125 $(11,722)$7,403 $19,125 $(13,544)$5,581 
Developed technology77,373 (17,499)59,874 80,166 (30,304)49,862 
Customer relationships6,459 (308)6,151 6,459 (1,246)5,213 
Trade name3,623 (403)3,220 3,623 (1,633)1,990 
Intangible assets, net$106,580 $(29,932)$76,648 $109,373 $(46,727)$62,646 
Intangible assets amortization expense was $9.3 million, $13.0 million and $16.8 million for fiscal 2020, 2021 and 2022, respectively. At the end of fiscal 2022, the weighted-average remaining amortization period was 2.0 years for technology patents, 3.9 years for developed technology, 5.6 years for customer relationships, and 1.6 years for trade name. We recorded amortization of technology patents in general and administrative expenses due to their defensive nature, developed technology in cost of product revenue, and customer relationships and trade name in sales and marketing expenses in the consolidated statements of operations.
At the end of fiscal 2022, future expected amortization expense for intangible assets is as follows (in thousands):
Fiscal Years Ending Future Expected 
Amortization
Expense
2023$16,197 
202415,776 
202514,991 
202612,396 
20272,673 
Thereafter613 
Total$62,646 
Goodwill
As of the end of fiscal 2021 and 2022, goodwill was $358.7 million. There were no impairments to goodwill during fiscal 2021 and 2022.
Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consist of the following (in thousands):
 
 At the End of Fiscal
 20212022
Taxes payable $4,097 $6,312 
Accrued marketing15,638 13,257 
Accrued cloud and outside services2,874 6,135 
Supply chain-related accruals7,461 6,991 
Accrued service logistics and professional services3,122 6,244 
Acquisition earn-out9,600 5,211 
Customer deposits from contracts with customers— 10,409 
Other accrued liabilities18,962 23,952 
Total accrued expenses and other liabilities$61,754 $78,511 
v3.22.1
Deferred Revenue and Commissions
12 Months Ended
Feb. 06, 2022
Revenue from Contract with Customer [Abstract]  
Deferred Revenue and Commissions Deferred Revenue and Commissions
Deferred Commissions
Changes in total deferred commissions during the periods presented are as follows (in thousands):
Fiscal Year Ended
20212022
Beginning balance$139,204 $187,924 
Additions183,151 217,595 
Recognition of deferred commissions(134,431)(159,212)
Ending balance$187,924 $246,307 
During fiscal 2020, 2021 and 2022, we recognized sales commission expenses of $142.5 million, $150.2 million, and $175.9 million, respectively. Of the $246.3 million total deferred commissions balance at the end of fiscal 2022, we expect to recognize approximately 33% as sales commission expense over the next 12 months and the remainder thereafter.
There was no impairment related to capitalized commissions for fiscal 2020, 2021 or 2022.
Deferred Revenue
Changes in total deferred revenue during the periods presented are as follows (in thousands):
Fiscal Year Ended
20212022
Beginning balance$697,288 $843,697 
Additions703,800 937,510 
Recognition of deferred revenue(557,391)(701,335)
Ending balance $843,697 $1,079,872 
During fiscal 2021 and 2022, we recognized approximately $353.1 million and $442.7 million, respectively, in revenue pertaining to deferred revenue as of the beginning of each period.
Remaining Performance Obligations
Total contracted but not recognized revenue was $1.4 billion at the end of fiscal 2022. Contracted but not recognized revenue consists of both deferred revenue and non-cancelable amounts that are expected to be invoiced and recognized as revenue in future periods. The value of orders that are contracted but have not been fulfilled and that can be canceled by customers, are excluded from remaining performance obligations. Of the $1.4 billion contracted but not recognized revenue at the end of fiscal 2022, we expect to recognize approximately 47% over the next 12 months, and the remainder thereafter.
v3.22.1
Debt
12 Months Ended
Feb. 06, 2022
Debt Disclosure [Abstract]  
Debt Debt
Convertible Senior Notes
In April 2018, we issued $575.0 million in principal amount of 0.125% convertible senior notes due 2023, in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act and received proceeds of $562.1 million, after deducting the underwriters’ discounts and commissions. The Notes are governed by an indenture (the Indenture) between us, as the issuer, and U.S. Bank National Association, as trustee. The Notes are our senior unsecured obligations. The Indenture does not contain any financial covenants or restrictions on the payments of dividends, the incurrence of indebtedness, or the issuance or repurchase of securities by us or any of our subsidiaries. The Notes mature on April 15, 2023 unless repurchased or redeemed by us or converted in accordance with their terms prior to the maturity date. Interest is payable semi-annually in arrears on April 15 and October 15 of each year.
The Notes are convertible for up to 21,884,155 shares of our common stock at an initial conversion rate of approximately 38.0594 shares of common stock per $1,000 principal amount, which is equal to an initial conversion price of approximately $26.27 per share of common stock, subject to adjustment. Holders of the Notes may surrender their Notes for conversion at their option at any time prior to the close of business on the business day immediately preceding October 15, 2022, only under the following circumstances:
during any fiscal quarter if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day;
during the five business day period after any five consecutive trading day period (the measurement period), in which the trading price per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate for the Notes on each such trading day;
if we call any or all of the Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or
upon the occurrence of specified corporate events.
On or after October 15, 2022 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes at any time regardless of the foregoing circumstances. Upon conversion, holders will receive cash, shares of our common stock, or a combination of cash and shares of our common stock, at our election. We intend to settle the principal of the Notes in cash.
The conversion price will be subject to adjustment in some events. Following certain corporate events that occur prior to the maturity date or following our issuance of a notice of redemption, we will increase the conversion rate for a holder who elects to convert its Notes in connection with such corporate event or during the related redemption period in certain circumstances. Additionally, upon the occurrence of a corporate event that constitutes a “fundamental change” per the Indenture, holders of the Notes may require us to repurchase for cash all or a portion of the Notes at a purchase price equal to 100% of the principal amount of the Notes plus accrued and unpaid contingent interest.
Subsequent to April 19, 2021, we may redeem for cash all or any portion of the Notes, at our option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending not more than two trading days immediately preceding the date on which we provide notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Notes.
Upon the issuance of the Notes, we recorded total debt issuance costs of $12.9 million, of which $9.8 million was allocated to the Notes and $3.1 million was allocated to additional paid-in capital.
The Notes consisted of the following (in thousands):

At the End of Fiscal
20212022
Liability:
Principal$575,000 $575,000 
Less: debt discount, net of amortization(64,515)(35,641)
Less: debt issuance costs, net of amortization(4,671)(2,580)
Net carrying amount of the Notes$505,814 $536,779 
Stockholders' equity recorded at issuance:
Allocated value of the conversion feature$136,333 
Less: debt issuance costs(3,068)
Additional paid-in capital$133,265 
The total estimated fair values of the Notes at the end of fiscal 2021 and 2022 were $649.0 million and $681.8 million. The fair values were determined based on the closing trading price per $100 of the Notes as of the last day of trading of fiscal 2021 and 2022. The fair value of the Notes is primarily affected by the trading price of our common stock and market interest rates. Based on the closing price of our common stock of $26.38 on the last day of fiscal 2022, the if-converted value of the Notes of $577.3 million was greater than its principal amount. At the end of fiscal 2022, the remaining term of the Notes is 14 months.
The following table sets forth total interest expense recognized related to the Notes (in thousands):

Fiscal Year Ended
20212022
Amortization of debt discount$26,863 $28,874 
Amortization of debt issuance costs1,944 2,091 
Total amortization of debt discount and debt issuance costs28,807 30,965 
Contractual interest expense718 732 
Total interest expense related to the Notes$29,525 $31,697 
Effective interest rate of the liability component5.6 %5.6 %
In connection with the offering of the Notes, we paid $64.6 million to enter into capped call transactions with certain of the underwriters and their affiliates (the Capped Calls), whereby we have the option to purchase up to a total of 21,884,155 shares of our common stock to offset the dilution and/or any cash payments we are required to make in excess of the principal amount upon conversion of the Notes at maturity, with such offset subject to a cap of $39.66 per share (which represents a premium of 100% over the last reported sales price of our common stock on April 4, 2018), subject to certain adjustments (the Cap Price). However, for conversions prior to maturity, the Capped Calls would be settled at their fair value, which may not completely offset, and may be substantially less than, the value of the consideration in excess of the principal amount of the Notes delivered upon such conversion. The cost of the Capped Calls was accounted for as a reduction to additional paid-in capital on the consolidated balance sheet.
Impact on Earnings Per Share
The Notes will not impact our diluted earnings per share until the average market price of our common stock exceeds the conversion price of $26.27 per share, as we intend to settle the principal amount of the Notes in cash upon conversion. We are required under the treasury stock method to compute the potentially dilutive shares of common stock related to the Notes for periods we report net income. Upon conversion at maturity, there will be no economic dilution from the Notes until the average market price of our common stock exceeds the Cap Price of $39.66 per share as the exercise of the Capped Calls would offset any dilution from the Notes from the conversion price up to the Cap Price. However, for conversions prior to maturity, the Capped Calls would be settled at their fair value, which is expected to substantially, but not completely, offset the economic dilution from the Notes from the conversion price up to the Cap Price. Capped Calls are excluded from the calculation of diluted earnings per share, as they would be anti-dilutive under the treasury stock method.
Revolving Credit Facility
In August 2020, we entered into a Credit Agreement with a consortium of financial institutions and lenders that provides for a five-year, senior secured revolving credit facility of $300.0 million (Credit Facility). Proceeds from the Credit Facility may be used for general corporate purposes and working capital. The Credit Facility expires, absent default or early termination by us, on the earlier of (i) August 24, 2025 or (ii) 91 days prior to the stated maturity of the Notes unless, on such date and each subsequent day until the Notes are paid in full, the sum of our cash, cash equivalents and marketable securities and the aggregate unused commitments then available to us exceed $625.0 million.
The annual interest rates applicable to loans under the Credit Facility are, at our option, equal to either a base rate plus a margin ranging from 0.50% to 1.25% or LIBOR (based on one, three or six-month interest periods), subject to a floor of 0%, plus a margin ranging from 1.50% to 2.25%. Interest on revolving loans is payable quarterly in arrears with respect to loans based on the base rate and at the end of an interest period in the case of loans based on LIBOR (or at each three-month interval if the interest period is longer than three months). We are also required to pay a commitment fee on the unused portion of the commitments ranging from 0.25% to 0.40% per annum, payable quarterly in arrears.
In September 2020, we drew down $250.0 million under the Credit Facility which remained outstanding at the end of fiscal 2022. The outstanding loan bore weighted-average interest at the one-month LIBOR of approximately 1.65% and 1.60% resulting in interest expense of $1.4 million and $4.1 million during fiscal 2021 and 2022. In February 2022, we repaid, in full, the $250.0 million outstanding under the Credit Facility.
Loans under the Credit Facility are collateralized by substantially all of our assets and subject to certain restrictions and two financial ratios measured as of the last day of each fiscal quarter: a Consolidated Leverage Ratio not to exceed 4.5:1 and an Interest Coverage Ratio not to be less than 3:1. We were in compliance with all covenants under the Credit Facility at the end of fiscal 2022.
v3.22.1
Commitments and Contingencies
12 Months Ended
Feb. 06, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Leases
At the end of fiscal 2022, we had various non-cancelable operating and finance lease commitments for office facilities. Refer to Note 9—Leases for additional information regarding lease commitments.
Contractual Purchase Obligations
At the end of fiscal 2022, we had $289.0 million of non-cancelable contractual purchase obligations primarily related to inventory purchase commitments, software service and sponsorship contracts, and hosting arrangements. We have various manufacturing contracts with vendors in the conduct of the normal course of business. In order to manage future demand for its products, we enter into agreements with manufacturers and suppliers to procure inventory based upon certain criteria and timing.
Letters of Credit
At the end of fiscal 2021 and 2022, we had outstanding letters of credit in the aggregate amount of $6.7 million, in connection with our facility leases. The letters of credit are collateralized by restricted cash and mature on various dates through August 2029.
Legal Matters
From time to time, we have become involved in claims and other legal matters arising in the normal course of business. We investigate these claims as they arise. Although claims are inherently unpredictable, we currently are not aware of any matters that we expect to have a material adverse effect on our business, financial position, results of operations or cash flows. Accordingly, we have not recorded any loss contingency on our consolidated balance sheet as of the end of fiscal 2022.
Indemnification
Our arrangements generally include certain provisions for indemnifying customers against liabilities if our products or services infringe a third party’s intellectual property rights. Other guarantees or indemnification arrangements include guarantees of product and service performance and standby letters of credit for lease facilities. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, we have not incurred any material costs as a result of such obligations and have not accrued any liabilities related to such obligations in the consolidated financial statements. In addition, we indemnify our officers, directors and certain key employees while they are serving in good faith in their respective capacities. To date, there have been no claims under any indemnification provisions.
v3.22.1
Leases
12 Months Ended
Feb. 06, 2022
Leases [Abstract]  
Leases Leases
We lease office facilities under non-cancelable operating lease agreements expiring through July 2032. Our lease agreements do not contain any material residual value guarantees or restrictive covenants. During fiscal 2021, we ceased use of certain leased facilities that resulted in the recognition of certain exit costs - see Note 10 for further information. In fiscal 2022, we entered into an agreement with a third party vendor to finance lease certain test equipment. The amount of test equipment acquired under the finance lease was not material.
The components of lease costs were as follows (in thousands):

Fiscal Year Ended
20212022
Fixed operating lease cost$37,411 $37,598 
Variable lease cost (1)
9,168 10,228 
Short-term lease cost (12 months or less)5,734 4,178 
Total lease cost$52,313 $52,004 

(1) Variable lease cost predominantly included common area maintenance charges.

At the end of fiscal 2021, the weighted-average remaining lease term for our operating leases was 5.2 years, and the weighted-average discount rate for our operating leases was 5.8%. At the end of fiscal 2022, the weighted-average remaining lease term for our operating leases is 4.5 years, and the weighted-average discount rate for our operating leases was 5.7%. Future lease payments under our non-cancelable operating leases at the end of fiscal 2022 are as follows (in thousands):
Fiscal Years EndingOperating Leases
2023$38,627 
202433,565 
202528,980 
202620,314 
20278,266 
Thereafter17,787 
Total future lease payments$147,539 
Less: imputed interest(18,962)
Present value of lease liabilities$128,577 
v3.22.1
Restructuring and Other
12 Months Ended
Feb. 06, 2022
Restructuring and Related Activities [Abstract]  
Restructuring and Other Restructuring and Other
During fiscal 2021, we ceased use of certain leased facilities and recorded an impairment charge of $7.5 million for operating lease right-of-use assets and leasehold improvements for these leases. In addition, we recognized a liability of $2.4 million for the remaining lease costs that will continue to be incurred without benefit to us.
During fiscal 2021, we effected workforce realignment plans to streamline our operations and recognized $12.2 million of restructuring costs related to one-time involuntary termination benefit costs. The restructuring charges are included in restructuring and other expenses in our consolidated statement of operations. There was no remaining liability for unpaid amounts at the end of fiscal 2022.
During fiscal 2021, we incurred incremental costs of $9.8 million directly related to the COVID-19 pandemic. These costs primarily included the write-off of marketing commitments no longer deemed to have value for the remainder of fiscal 2021, estimated non-recoverable costs for internal events that could not be held, and hazard related premiums to support manufacturing operations. Of these costs, $8.9 million is included in restructuring and other expenses and $0.9 million is included in cost of revenue in our consolidated statements of operations for fiscal 2021.
v3.22.1
Stockholders' Equity
12 Months Ended
Feb. 06, 2022
Equity [Abstract]  
Stockholders’ Equity Stockholders’ Equity
Preferred Stock
We have 20,000,000 authorized shares of undesignated preferred stock, the rights, preferences and privileges of which may be designated from time to time by our board of directors. At the end of fiscal 2022, there were no shares of preferred stock issued or outstanding.
Class A and Class B Common Stock
We have two classes of authorized common stock, Class A common stock, which we refer to as our "common stock", and Class B common stock. We have 2,000,000,000 authorized shares of Class A common stock and 250,000,000 authorized shares of Class B common stock, with each class having a par value of $0.0001 per share. At the end of fiscal 2022, 292,632,893 shares of Class A common stock were issued and outstanding.
Common Stock Reserved for Issuance
At the end of fiscal 2022, we had reserved shares of common stock for future issuance as follows:
Shares underlying outstanding stock options12,268,938 
Shares underlying outstanding restricted stock units28,712,878 
Shares reserved for future equity awards17,402,448 
Shares reserved for future employee stock purchase plan awards5,283,083 
Total63,667,347 
Share Repurchase Program
In August 2019, our board of directors approved a stock repurchase program to repurchase up to $150.0 million of our common stock, which was completed in the fourth quarter of fiscal 2021. In February 2021, our board of directors authorized the repurchase of up to an additional $200.0 million of our common stock, which was completed in the fourth quarter of fiscal 2022. In March 2022, our board of directors authorized the repurchase of up to an additional $250.0 million of our common stock. The authorization allows us to repurchase shares of our common stock opportunistically and will be funded from available working capital. Repurchases may be made at management’s discretion from time to time on the open market through privately negotiated transactions, transactions structured through investment banking institutions, block purchase techniques, 10b5-1 trading plans, or a combination of the foregoing. The share repurchase program does not obligate us to acquire any of our common stock, has no end date, and may be suspended or discontinued by us at any time without prior notice. As of April 5, 2022, $231.9 million of the repurchase authorization remained available.
We record the difference between cash paid for stock repurchases and underlying par value as a reduction to additional paid-in capital, to the extent the repurchases does not cause this balance to be reduced below zero, at which point the difference would be recorded as a reduction to accumulated deficit. During fiscal 2020, we repurchased and retired 867,657 shares of common stock at an average purchase price of $17.29 per share for an aggregate repurchase price of $15.0 million. During fiscal 2021, we repurchased and retired 9,526,556 shares of common stock at an average purchase price of $14.17 per share for an aggregate repurchase price of $135.0 million. During fiscal 2022, we repurchased and retired 8,489,168 shares of common stock at an average purchase price of $23.56 per share for an aggregate repurchase price of $200.0 million.
v3.22.1
Equity Incentive Plans
12 Months Ended
Feb. 06, 2022
Share-based Payment Arrangement [Abstract]  
Equity Incentive Plans Equity Incentive Plans
Equity Incentive Plans
We maintain two equity incentive plans: the 2009 Equity Incentive Plan (the 2009 Plan) and the 2015 Equity Incentive Plan (the 2015 Plan). The 2015 Plan serves as the successor to our 2009 Plan and provides for grants of incentive stock options to our employees and non-statutory stock options, stock appreciation rights, restricted stock, RSUs, performance stock awards, performance cash awards, and other forms of stock awards to our employees, directors and consultants. Outstanding awards granted under our 2009 Plan will remain subject to the terms of our 2009 Plan and applicable award agreements, until such outstanding awards that are stock options are exercised, terminated or expired by their terms. Our equity awards generally vest over a two to four year period and expire no later than ten years from the date of grant.
We initially reserved 27,000,000 shares of our common stock for issuance under our 2015 Plan. The number of shares reserved for issuance under our 2015 Plan increases automatically on the first day of each fiscal year, for a period of not more than ten years, commencing on February 1, 2016, in an amount equal to 5% of the total number of shares of our capital stock outstanding as of the immediately preceding January 31 (the Evergreen Increase). In March 2022, our board of directors approved an amendment and restatement of the 2015 Plan to clarify the effect of our change to a 52/53 week fiscal year in September 2019 on the Evergreen Increase.
We net-share settle equity awards held by certain employees by withholding shares upon vesting to satisfy tax withholding obligations. The shares withheld to satisfy employee tax withholding obligations are returned to our 2015 Plan and will be available for future issuance. Payments for employees’ tax obligations to the tax authorities are recognized as a reduction to additional paid-in capital and reflected as a financing activity in our consolidated statements of cash flows.
2015 Amended and Restated Employee Stock Purchase Plan
Our 2015 Employee Stock Purchase Plan was amended and restated in fiscal 2020 (2015 ESPP). A total of 3,500,000 shares of common stock was initially reserved for issuance under the 2015 ESPP and an additional 5,000,000 shares of common stock were added in connection with the amendment and restatement. The number of shares reserved for issuance under our 2015 ESPP increases automatically on the first day of February of each of 2016 through 2025, in an amount equal to the lesser of (i) 1% of the total number of shares of our capital stock outstanding as of the immediately preceding January 31, and (ii) 3,500,000 shares of common stock.
Our board of directors (or a committee thereof) has the authority to establish the length and terms of the offering periods and purchase periods and the purchase price of the shares of common stock which may be purchased under the plan. The current offering terms allow eligible employees to purchase shares of our common stock at a discount through payroll deductions of up to 30% of their eligible compensation, subject to a cap of 3,000 shares on any purchase date, a dollar cap of $7,500 per purchase period (instituted in February 2019), or $25,000 in any calendar year (as determined under applicable tax rules). The current terms also allow for a 24-month offering period beginning March 16th and September 16th of each year, with each offering period consisting of four 6 month purchase periods, subject to a reset provision. Further, currently, on each purchase date, eligible employees may purchase our common stock at a price per share equal to 85% of the lesser of the fair market value of our common stock (1) on the first trading day of the applicable offering period or (2) the purchase date.
Under the reset provision currently authorized, if the closing stock price on the offering date of a new offering falls below the closing stock price on the offering date of an ongoing offering, the ongoing offering would terminate immediately following the purchase of ESPP shares on the purchase date immediately preceding the new offering and participants in the terminated ongoing offering would automatically be enrolled in the new offering (ESPP reset), resulting in a modification charge to be recognized over the new offering period. During fiscal 2020 and 2021, multiple ESPP resets resulted in total modification charges of $13.6 million and $23.8 million to be recognized over their new offering periods. There was no ESPP reset during fiscal 2022.
During fiscal 2020, 2021 and 2022, we recognized $24.5 million, $25.8 million and $35.4 million, of stock-based compensation expense related to our 2015 ESPP. At the end of fiscal 2022, total unrecognized stock-based compensation cost related to our 2015 ESPP was $9.9 million, which is expected to be recognized over a weighted-average period of approximately 0.8 years.
Stock Options
A summary of the stock option activity under our equity incentive plans and related information is as follows:
 
 Options Outstanding
 Number of
Shares
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
(in thousands)
Balance at the end of fiscal 202118,558,974 $9.60 4.3$251,503 
Options exercised(5,954,724)8.15   
Options forfeited/canceled(335,312)11.50   
Balance at the end of fiscal 202212,268,938 $10.25 3.5$198,266 
Vested and exercisable at the end of fiscal 202211,565,305 $10.73 3.2$180,978 
The aggregate intrinsic value of options vested and exercisable at the end of fiscal 2022 is calculated based on the difference between the exercise price and the closing price of $26.38 of our common stock on the last day of fiscal 2022. The aggregate intrinsic value of options exercised during fiscal 2020, 2021 and 2022 was $106.6 million, $118.8 million and $105.1 million.
The total grant date fair value of options vested during fiscal 2020, 2021 and 2022 was $34.2 million, $20.1 million and $16.5 million.
During fiscal 2020, 2021 and 2022, we recognized $15.8 million, $8.6 million and $7.7 million, of stock-based compensation expense related to stock options. At the end of fiscal 2022, total unrecognized employee stock-based compensation cost related to outstanding options was $7.5 million, which is expected to be recognized over a weighted-average period of 1.6 years.
Determination of Fair Value
The fair value of stock options granted to employees and to be purchased under ESPP is estimated on the grant date using the Black-Scholes option pricing model. This valuation model for stock-based compensation expense requires us to make assumptions and judgments about the variables used in the calculation including the fair value of the underlying common stock, expected term, the expected volatility of the common stock, a risk-free interest rate and expected dividend yield. The assumptions used for the periods presented are as follows:
 
 Fiscal Year Ended
 202020212022
Employee Stock Options   
Expected term (in years)n/a5.65n/a
Expected volatilityn/a52.07%n/a
Risk-free interest raten/a0.3%n/a
Dividend raten/an/a
Fair value of common stockn/a$15.79n/a
Employee Stock Purchase Plan   
Expected term (in years)
0.5 - 2.0
0.5 - 2.0
0.5 - 2.0
Expected volatility
42% - 47%
52% - 113%
44% - 61%
Risk-free interest rate
1.7% - 2.5%
0.1% - 0.4%
0.1% - 0.2%
Dividend rate
Fair value of common stock
$17.76 - $20.87
$9.07 - $15.26
$23.63 - $26.69
 
The assumptions used in the Black-Scholes option pricing model were determined as follows.
Fair Value of Common Stock—We use the market closing price of our common stock as reported on the New York Stock Exchange to determine the fair value of our common stock at each grant date.
Expected Term—The expected term represents the period that our stock-based awards are expected to be outstanding. The expected term assumptions were determined based on the vesting terms, exercise terms and contractual lives of the options and ESPP purchase rights.
Expected Volatility—The expected volatility for ESPP purchase rights is based on the historical volatility of our common stock for a period equivalent to the expected term of the ESPP purchase rights.
Risk-Free Interest Rate—The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities approximately equal to the expected term of the stock option grants and ESPP purchase rights.
Dividend Rate—We have never declared or paid any cash dividends and do not plan to pay cash dividends in the foreseeable future, and, therefore, use an expected dividend yield of zero.
RSUs and PRSUs
A summary of the RSU and PRSU activity under our equity incentive plans and related information is as follows:
Number of RSUs and PRSUs OutstandingWeighted-Average Grant Date Fair ValueAggregate Intrinsic Value
(in thousands)
Unvested balance at the end of fiscal 202130,830,082 $15.77 $712,657 
Granted17,173,968 23.42 
Vested(12,955,468)17.07 
Forfeited(6,335,704)16.60 
Unvested balance at the end of fiscal 202228,712,878 $19.53 $757,446 
During fiscal 2022, we granted 1,600,373 shares of PRSUs, at a target percentage of 100%, with both performance and service vesting conditions payable in common stock, from 0% to 150% of the target number granted, contingent upon the degree to which the performance condition is met. A total of 2,028,355 shares were earned at the end of fiscal 2022 based on the performance condition achieved and these shares are subject to service conditions through the vesting periods.
The aggregate fair value, as of the respective vesting dates, of RSUs and PRSUs that vested during fiscal 2020, 2021 and 2022 was $164.1 million, $183.4 million and $322.2 million.
During fiscal 2020, 2021 and 2022, we recognized $161.8 million, $199.1 million and $242.1 million in stock-based compensation expense related to RSUs and PRSUs. At the end of fiscal 2022, total unrecognized employee compensation cost related to unvested RSUs and PRSUs was $503.2 million, which is expected to be recognized over a weighted-average period of 2.7 years.
Restricted Stock
A summary of the restricted stock activity under our 2015 Plan and related information is as follows:
 Number of Restricted Stock OutstandingWeighted-
Average
Grant Date
Fair Value
Aggregate
Intrinsic
Value
(in thousands)
Unvested balance at the end of fiscal 2021557,836 $19.06 $12,903 
Vested(440,687)18.78 
Forfeited(62,172)20.22 
Unvested balance at the end of fiscal 202254,977 $20.02 $1,450 
All unvested shares of restricted stock are subject to cancellation to the extent vesting conditions are not met. The aggregate fair value of restricted stock that vested during fiscal 2020, 2021 and 2022 was $24.2 million, $18.3 million and $10.4 million.
During fiscal 2020, 2021 and 2022, we recognized $24.6 million, $9.3 million and $1.8 million in stock-based compensation expense related to restricted stock. At the end of fiscal 2022, total unrecognized employee compensation cost related to unvested restricted stock was not material, which is expected to be recognized over a weighted-average period of approximately 0.1 years.
Stock-Based Compensation Expense
The following table summarizes the components of stock-based compensation expense recognized in the consolidated statements of operations (in thousands):
 Fiscal Year Ended
 202020212022
Cost of revenue—product$3,732 $4,001 $6,334 
Cost of revenue—subscription services14,403 14,979 21,240 
Research and development107,658 117,220 142,264 
Sales and marketing67,560 65,248 71,439 
General and administrative33,352 40,896 45,686 
Total stock-based compensation expense$226,705 $242,344 $286,963 
The tax benefit related to stock-based compensation expense for all periods presented was not material.
v3.22.1
Net Loss per Share Attributable to Common Stockholders
12 Months Ended
Feb. 06, 2022
Earnings Per Share [Abstract]  
Net Loss per Share Attributable to Common Stockholders Net Loss per Share Attributable to Common Stockholders
Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. Diluted net loss per share attributable to common stockholders is computed by giving effect to all potentially dilutive common stock equivalents, including our outstanding stock options, common stock related to unvested RSUs and PRSUs, unvested restricted stock, our Notes to the extent dilutive, and common stock issuable pursuant to the ESPP. These potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive.
The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):
 
 Fiscal Year Ended
 202020212022
 
Net loss$(200,987)$(282,076)$(143,259)
Weighted-average shares used in computing net loss
   per share attributable to common stockholders, basic and diluted
252,820 267,824 285,882 
Net loss per share attributable to common stockholders,
basic and diluted
$(0.79)$(1.05)$(0.50)
 
The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):
 
 Fiscal Year Ended
 202020212022
Stock options to purchase common stock31,315 23,180 15,686 
Unvested RSUs and PRSUs24,374 31,980 32,491 
Unvested restricted stock2,614 1,145 257 
Shares related to convertible senior notes21,884 21,884 21,884 
Shares issuable pursuant to the ESPP1,031 2,148 2,122 
Total81,218 80,337 72,440 
v3.22.1
Other Income (Expense), Net
12 Months Ended
Feb. 06, 2022
Other Income and Expenses [Abstract]  
Other Income (Expense), Net Other Income (Expense), Net
Other income (expense), net consists of the following (in thousands):
Fiscal Year Ended
202020212022
Interest income (1)
$27,241 $17,442 $9,371 
Interest expense (2)
(27,897)(31,403)(36,677)
Foreign currency transactions (losses) gains(3,396)2,507 (5,235)
Other income669 2,327 2,443 
Total other income (expense), net$(3,383)$(9,127)$(30,098)
_________________________________
(1) Interest income includes interest income related to our cash, cash equivalents and marketable securities and non-cash interest income (expense) related to accretion (amortization) of the discount (premium) on marketable securities.
(2) Interest expense includes non-cash interest expense related to amortization of the debt discount and debt issuance costs and the contractual interest expense related to our debt.
v3.22.1
Income Taxes
12 Months Ended
Feb. 06, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The geographical breakdown of loss before provision for income taxes is as follows (in thousands):

 Fiscal Year Ended
 202020212022
Domestic$(212,672)$(312,119)$(192,058)
International18,006 41,959 63,562 
Total$(194,666)$(270,160)$(128,496)

The components of the provision for income taxes are as follows (in thousands):

 Fiscal Year Ended
 202020212022
Current:   
State$538 $442 $592 
Foreign7,774 8,006 12,525 
Total$8,312 $8,448 $13,117 
Deferred:   
Federal$(1,559)$(218)$— 
State(198)— — 
Foreign(234)3,686 1,646 
Total$(1,991)$3,468 $1,646 
Provision for income taxes$6,321 $11,916 $14,763 
 
The reconciliation of income taxes at the federal statutory income tax rate to the provision for income taxes is as follows (in thousands):
 Fiscal Year Ended
 202020212022
Tax at federal statutory rate$(40,880)$(56,734)$(26,984)
State tax, net of federal benefit210 349 468 
Stock-based compensation expense(6,683)(604)(19,658)
Research and development tax credits(11,033)(14,138)(16,783)
U.S. taxes on foreign income— 14,021 25,059 
Foreign rate differential2,935 2,282 (1,698)
Change in valuation allowance61,050 63,146 48,270 
Non-deductible expenses— — 4,381 
Other722 3,594 1,708 
Provision for income taxes$6,321 $11,916 $14,763 

Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of our deferred tax assets and liabilities were as follows (in thousands):
 At the End of Fiscal
 20212022
Deferred tax assets:  
Net operating loss carryforwards$308,250 $369,904 
Tax credit carryover104,247 134,085 
Accruals and reserves22,263 22,625 
Deferred revenue69,886 66,242 
Stock-based compensation expense28,310 25,247 
Depreciation and amortization120 — 
Charitable contribution carryforwards229 290 
Interest expense limitation (163(j))110 — 
ASC 842 lease liabilities33,302 28,577 
Other— 1,589 
Total deferred tax assets$566,717 $648,559 
Valuation allowance(484,437)(554,553)
Total deferred tax assets, net of valuation allowance$82,280 $94,006 
Deferred tax liabilities:  
Depreciation and amortization$— $(12,992)
Deferred commissions(41,526)(53,219)
Convertible debt(8,147)(4,642)
ASC 842 right-of-use assets(29,183)(24,608)
Acquired intangibles and goodwill(8,727)(6,850)
Intercompany interest— (874)
Other(2,230)— 
Total deferred tax liabilities$(89,813)$(103,185)
Net deferred tax liabilities$(7,533)$(9,179)
At the end of fiscal 2022, the undistributed earnings of $134.2 million from non-U.S. operations held by our foreign subsidiaries are designated as permanently reinvested outside the U.S. Accordingly, no additional U.S. income taxes or additional foreign withholding taxes have been provided thereon. Determination of the amount of unrecognized deferred tax liability related to these earnings is not practicable.
At the end of fiscal 2022, we had net operating loss carryforwards for federal income tax purposes of approximately $1.5 billion and state income tax purposes of approximately $858.7 million. These net operating loss carryforwards will expire, if not utilized, beginning in 2028 for federal and state income tax purposes.
We had federal and state research and development tax credit carryforwards of approximately $98.7 million and $88.0 million at the end of fiscal 2022. The federal research and development tax credit carryforwards will expire commencing in 2028, while the state research and development tax credit carryforwards have no expiration date.
Realization of deferred tax assets is dependent on future taxable income, the existence and timing of which is uncertain. Based on our history of losses, management has determined that it is more likely than not that the U.S. deferred tax assets will not be realized, and accordingly has placed a full valuation allowance on the net U.S. deferred tax assets. The valuation allowance increased by $98.6 million and $70.1 million, respectively, during fiscal 2021 and 2022.
Utilization of the net operating loss carryforwards and credits may be subject to substantial annual limitation due to the ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization.
Uncertain Tax Positions
The activity related to the unrecognized tax benefits is as follows (in thousands):
 Fiscal Year Ended
 202020212022
Gross unrecognized tax benefits—beginning balance$18,891 $28,570 $39,571 
Decreases related to tax positions taken during prior years(34)(345)(173)
Increases related to tax positions taken during prior years408 1,881 1,201 
Increases related to tax positions taken during current year
9,305 9,465 10,983 
Gross unrecognized tax benefits—ending balance$28,570 $39,571 $51,582 
At the end of fiscal 2022, our gross unrecognized tax benefit was approximately $51.6 million, $3.5 million of which if recognized, would have an impact on the effective tax rate.
At the end of fiscal 2022, we had no current or cumulative interest and penalties related to uncertain tax positions.
It is difficult to predict the final timing and resolution of any particular uncertain tax position. Based on our assessment, including experience and complex judgments about future events, we do not expect that changes in the liability for unrecognized tax benefits during the next twelve months will have a significant impact on our consolidated financial position or results of operations.
We file income tax returns in the U.S. federal jurisdiction as well as many U.S. states and foreign jurisdictions. The tax returns for fiscal years 2009 and forward remain open to examination by the major jurisdictions in which we are subject to tax. The tax returns for fiscal years outside the normal statutes of limitation remain open to audit by tax authorities due to tax attributes generated in those early years, which have been carried forward and may be audited in subsequent years when utilized.
v3.22.1
Segment Information
12 Months Ended
Feb. 06, 2022
Segment Reporting [Abstract]  
Segment Information Segment Information
Our chief operating decision maker is our Chief Executive Officer. Our chief operating decision maker reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we have a single reportable segment.
Disaggregation of Revenue
The following table depicts the disaggregation of revenue by geographic area based on the billing address of our customers and is consistent with how we evaluate our financial performance (in thousands):
 
 Fiscal Year Ended
 202020212022
United States$1,184,923 $1,195,428 $1,580,022 
Rest of the world458,517 488,751 600,826 
Total revenue$1,643,440 $1,684,179 $2,180,848 

Long-Lived Assets by Geographic Area
Long-lived assets, which are comprised of property and equipment, net, by geographic area are summarized as follows (in thousands):
 At the End of Fiscal
 20212022
United States$152,859 $187,228 
Rest of the world10,182 8,054 
Total long-lived assets$163,041 $195,282 
v3.22.1
401(k) Plan
12 Months Ended
Feb. 06, 2022
Compensation Related Costs [Abstract]  
401(k) Plan 401(k) PlanWe have a 401(k) savings plan (the 401(k) plan) which qualifies as a deferred salary arrangement under section 401(k) of the Internal Revenue Code. Under the 401(k) plan, participating employees may elect to contribute up to 85% of their eligible compensation, subject to certain limitations. We currently match 50% of employees' contributions up to a maximum of $4,000 annually. Matching contributions immediately vest. Our contributions to the plan were $8.6 million, $10.2 million and $11.1 million during fiscal 2020, 2021 and 2022.
v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
12 Months Ended
Feb. 06, 2022
Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation
Basis of Presentation and Principles of Consolidation
We operate using a 52/53 week fiscal year ending on the first Sunday after January 30. Fiscal 2020 and 2021 were both 52-week years that ended on February 2, 2020 and January 31, 2021, respectively. Fiscal 2022 was a 53-week year that ended on February 6, 2022. Unless otherwise stated, all dates refer to our fiscal years.
The consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries and have been prepared in conformity with accounting principles generally accepted in the United States (U.S. GAAP). All intercompany balances and transactions have been eliminated in consolidation.
Foreign Currency
Foreign Currency
The functional currency of our foreign subsidiaries is the U.S. dollar. Transactions denominated in currencies other than the functional currency are remeasured to the functional currency at the average exchange rate in effect during the period. At the end of each reporting period, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Foreign currency transaction gains and losses are recorded in other income (expense), net in the consolidated statements of operations.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Actual results could differ from these estimates and assumptions due to risks and uncertainties. Such estimates include, but are not limited to, the determination of standalone selling price for revenue arrangements with multiple performance obligations when the price at which the performance obligation sold separately or observable past transactions are not available, useful lives of intangible assets and property and equipment, the period of benefit for deferred contract costs for commissions, stock-based compensation, provision for income taxes including related reserves, fair value of equity assumed, intangible and tangible assets acquired and liabilities assumed for business combinations. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Concentration Risk Concentration RiskFinancial instruments that are exposed to concentration of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable.
Cash and Cash Equivalents
Cash and Cash Equivalents
Cash and cash equivalents consist of cash in banks and highly liquid investments, primarily money market accounts, purchased with an original maturity of three months or less.
Marketable Securities
Marketable Securities
We classify our marketable securities as available-for-sale (AFS) at the time of purchase and reevaluate such classification at each balance sheet date. We may sell these securities at any time for use in current operations even if they have not yet reached maturity. As a result, we classify our securities, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. We carry these securities at estimated fair value and record unrealized gains and losses in accumulated other comprehensive income (loss), which is reflected as a component of stockholders' equity. We evaluate our AFS debt securities with an unamortized cost basis in excess of estimated fair value to determine what amount of that difference, if any, is caused by expected credit losses. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized through an allowance for credit losses with changes in the allowance for credit losses recognized as a charge to other income (expense), net, in the consolidated statements of operations. Any remaining impairment is included in accumulated other comprehensive income (loss) as a component of stockholders' equity. Realized gains and losses from the sale of marketable securities are determined based on the specific identification method. Realized gains and losses are reported in other income (expense), net in the consolidated statements of operations.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The carrying value of our financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximates fair value.
Accounts Receivable and Allowance
Accounts Receivable and Allowance
Accounts receivable are recorded at the invoiced amount, and stated at realizable value, net of an allowance for doubtful accounts. Credit is extended to partners and customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable. We perform ongoing credit evaluations and maintain an allowance for doubtful accounts.
We assess the collectability of the accounts by taking into consideration the aging of our trade receivables, historical experience, and management judgment. We write off trade receivables against the allowance when management determines a balance is uncollectible and no longer actively pursues collection of the receivable.
Restricted Cash Restricted CashRestricted cash is comprised of cash collateral for letters of credit related to our leases and for a vendor credit card program.
Inventory
Inventory
Inventory consists of finished goods and component parts, which are purchased from contract manufacturers. Product demonstration units, which we regularly sell, are the primary component of our inventories. Inventories are stated at the lower of cost or net realizable value. Cost is determined using the specific identification method for finished goods and weighted-average method for component parts. We account for excess and obsolete inventory by reducing the carrying value to the estimated net realizable value of the inventory based upon management’s assumptions about future demand and market conditions. In addition, we record a liability for firm, non-cancelable and unconditional purchase commitments with contract manufacturers and suppliers for quantities in excess of future demand forecasts consistent with excess and obsolete inventory valuations. Inventory write-offs were insignificant for fiscal 2020, 2021 and 2022.
Property and Equipment, Net
Property and Equipment, Net
Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the respective assets (test equipment—4 years, computer equipment and software—4 years, furniture and fixtures—7 years). Leasehold improvements are amortized over the shorter of their estimated useful lives or the remaining lease term. Depreciation commences once the asset is placed in service.
In accordance with our accounting practices, we review the estimated useful lives of our property and equipment on an ongoing basis. In the first quarter of fiscal 2021, management determined that the estimated useful lives of its test equipment and certain computer equipment and software required revision. The estimated useful lives of test equipment and certain computer equipment and software were revised to 4 years. Previously, the estimated useful lives of these assets ranged from 2 to 3 years. The change in estimated useful lives was accounted for as a change in estimate and recognized on a prospective basis effective February 3, 2020. The effect of this change in estimate resulted in a reduction to depreciation expense of $23.6 million during fiscal 2021.
Business Combination
Business Combinations
We allocate the purchase price to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of the assets acquired and liabilities assumed is recorded as goodwill. During the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the estimated fair value of the assets acquired and liabilities assumed, with the corresponding offset to goodwill. The results of operations of an acquired business is included in our consolidated financial statements from the date of acquisition. Acquisition-related expenses are expensed as incurred.
Goodwill
Goodwill
Goodwill represents the excess of the purchase price consideration over the estimated fair value of the tangible and intangible assets acquired and liabilities assumed in a business combination. Goodwill is evaluated for impairment annually in the fourth quarter of our fiscal year as a single reporting unit, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. We may elect to qualitatively assess whether it is more likely than not that the fair value of our reporting unit is less than its carrying value. If we opt not to qualitatively assess, a quantitative goodwill impairment test is performed. The quantitative test compares our reporting unit's carrying amount, including goodwill, to its fair value calculated based on our enterprise value. If the carrying amount exceeds its fair value, an impairment loss is recognized for the excess. We did not recognize any impairment of goodwill in any of the periods presented in the consolidated financial statements.
Purchased Intangible Assets
Purchased Intangible Assets
Purchased intangible assets with finite lives are stated at cost, net of accumulated amortization. We amortize our intangible assets on a straight-line basis over an estimated useful life of three to seven years.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets
We review our long-lived assets, including property and equipment and finite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. We measure the recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If the total of the future undiscounted cash flows is less than the carrying amount of an asset, we record an impairment charge for the amount by which the carrying amount of the asset exceeds its fair market value.
Convertible Senior Notes
Convertible Senior Notes
In accounting for the issuance of our convertible senior notes (the Notes), we separated the Notes into liability and equity components. The carrying amount of the liability component was determined by measuring the fair value of a similar liability that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was calculated by deducting the fair value of the liability component from the principal amount of the Notes as a whole. The difference between the principal amount of the Notes and the liability component (the debt discount) is amortized to interest expense in the consolidated statements of operations using the effective interest method over the term of the Notes. The equity component of the Notes is included in additional paid-in capital in the consolidated balance sheets and is not remeasured as long as it continues to meet the conditions for equity classification. In accounting for the transaction costs related to the issuance of the Notes, we allocated the total amount incurred to the liability and equity components using the same proportions as the initial carrying value of the Notes. Transaction costs attributable to the liability component were netted with the principal amount of the Notes in the consolidated balance sheets and are being amortized to interest expense in the consolidated statements of operations using the effective interest method over the term of the Notes. Transaction costs attributable to the equity component were netted with the equity component of the Notes in additional paid-in capital in the consolidated balance sheets.
Deferred Commissions
Deferred Commissions
Deferred commissions consist of incremental costs paid to our sales force to obtain customer contracts. Deferred commissions related to product revenue are recognized upon transfer of control to customers and deferred commissions related to subscription services revenue are amortized over an expected useful life of six years. We determine the expected useful life based on an estimated benefit period by evaluating our technology development life cycle, expected customer relationship period and other factors. We classify deferred commissions as current and non-current on our consolidated balance sheets based on the timing of when we expect to recognize the expense. Amortization of deferred commissions is included in sales and marketing expense in the consolidated statements of operations.
Leases
Leases
We determine if an arrangement contains a lease at inception and classify leases as an operating or finance lease at commencement date. Lease liabilities are recognized at the present value of the future lease payments at commencement date. The interest rate implicit in our operating and finance leases is not readily determinable, and therefore an incremental borrowing rate is estimated to determine the present value of future payments. The estimated incremental borrowing rate factors in a hypothetical interest rate on a collateralized basis with similar terms, payments, and economic environments. The lease right-of-use (ROU) asset is determined based on the lease liability initially established and reduced for any prepaid lease payments and any lease incentives. We account for the lease and non-lease components of operating and finance lease contract consideration as a single lease component.
Certain of the operating lease agreements contain rent concession, rent escalation, and option to renew provisions. Rent concession and rent escalation provisions are considered in determining the lease cost. Lease cost under our operating leases is recognized on a straight-line basis over the lease term commencing on the date we have the right to use the leased property. For finance leases, we recognize amortization expense of the finance lease ROU asset on a straight-line basis over the shorter of its useful life or lease term and record interest expense for finance lease liabilities based on the incremental borrowing rate. We generally use the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that an extension or termination option will be exercised. Assets recognized and the short and long-term lease liabilities from finance leases are included in property and equipment, net, accrued expenses and other liabilities and other liabilities, non-current in the consolidated balance sheets.
In addition, certain of our operating lease agreements contain tenant improvement allowances from our landlords. These allowances are accounted for as lease incentives and reduce our ROU asset and lease cost over the lease term.
For short-term leases with lease term no longer than twelve months, and do not include an option to purchase the underlying asset that we are reasonably certain to exercise, we recognize rent expense in our consolidated statements of operations on a straight-line basis over the lease term and record variable lease payments as incurred.
Deferred Revenue and Revenue Recognition
Deferred Revenue
Deferred revenue primarily consists of amounts that have been invoiced but have not yet been recognized as revenue and performance obligations pertaining to subscription services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the consolidated balance sheet dates.
Revenue Recognition
We generate revenue from two sources: (1) product revenue which includes the sale of integrated storage hardware and embedded operating system software and (2) subscription services revenue which includes Evergreen Storage subscriptions, our unified subscription that includes Pure as-a-Service and Cloud Block Store, and Portworx. Subscription services revenue also include our professional services offerings such as installation and implementation consulting services.
We typically recognize product revenue upon transfer of control to our customers. Products are typically shipped directly by us to customers.
Our subscription services revenue is recognized ratably over the contractual term, which generally ranges from one to six years. The majority of our product solutions are sold with an Evergreen Storage subscription service agreement, which typically commences upon transfer of control of the corresponding products to our customers. Costs for subscription services are expensed when incurred. In addition, our Evergreen Storage subscription provides our customers with a new controller based upon certain contractual terms. The controller refresh represents a separate performance obligation that is included within the Evergreen Storage subscription service agreement and the allocated revenue is recognized upon shipment of the controller.
Our Evergreen Storage subscription services also include the right to receive unspecified software updates and upgrades on a when-and-if-available basis, software bug fixes, replacement parts and other services related to the underlying infrastructure, as well as access to our cloud-based management and support platform. We also sell professional services such as installation and implementation consulting services and the related revenue is recognized as services are performed.
We recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration we expect to be entitled in exchange for those goods or services. This is achieved through applying the following five-step approach:
Identification of the contract, or contracts, with a customer
Identification of the performance obligations in the contract
Determination of the transaction price
Allocation of the transaction price to the performance obligations in the contract
Recognition of revenue when, or as, we satisfy a performance obligation
When applying this five-step approach, we apply judgment in determining the customer's ability and intention to pay, which is based on a variety of factors including the customer's historical payment experience and/or published credit and financial information pertaining to the customer. To the extent a customer contract includes multiple promised goods or services, we determine whether promised goods or services should be accounted for as a separate performance obligation. The transaction price is determined based on the consideration which we will be entitled to in exchange for transferring goods or services to the customer. For contracts that contain multiple performance obligations, we allocate the transaction price to each performance obligation based on a relative standalone selling price. The standalone selling price is determined based on the price at which the performance obligation is sold separately, or if not observable through past transactions, is estimated taking into account available information such as market conditions and internally approved pricing guidelines related to performance obligations.
Warranty
Warranty
We generally provide a three-year warranty on hardware and a 90-day warranty on our software embedded in the hardware. Our hardware warranty provides for parts replacement for defective components and our software warranty provides for bug fixes. Our Evergreen Storage subscription agreement provides for the same parts replacement that customers are entitled to under our warranty program, except that replacement parts are delivered according to targeted response times to minimize disruption to our customers’ critical business applications. Substantially all customers purchase Evergreen Storage subscription agreements. As such, the warranty reserve at the end of fiscal 2022 was not material.
Research and Development Research and DevelopmentResearch and development costs are expensed as incurred. Research and development costs consist primarily of employee compensation and related expenses, prototype expenses, to the extent there is no alternative use for that equipment, depreciation of equipment used in research and development, third-party engineering and contractor support costs, data center and cloud services costs as well as allocated overhead costs.
Capitalized Internal-Use Software Costs
Capitalized Internal-Use Software Costs
We expense costs to develop software that is externally marketed before technological feasibility is reached. We have determined that technological feasibility is reached shortly before the release of our products and as a result, the development costs incurred after the establishment of technological feasibility and before the release of those products have not been significant and accordingly, all related software development costs have been expensed as incurred.
We capitalize (i) costs incurred to develop or modify software solely for our internal use, including hosted applications used to deliver our support services, and (ii) certain implementation costs incurred in a hosting arrangement that is a service contract when the preliminary project stage is complete, management with the relevant authority authorizes and commits to the funding of the software project, and it is probable the project will be completed and used to perform the intended function. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Software development costs are capitalized to property, plant and equipment and amortized using the straight-line method over an estimated useful life of four years. Software development costs capitalized to property and equipment were $0.7 million and $7.8 million for fiscal 2021 and 2022.
Software implementation costs are capitalized to either prepaid and other current assets or other assets, non-current on our consolidated balance sheet and amortized over the terms of the associated hosting arrangements. Software implementation costs capitalized were $1.9 million and $3.5 million for fiscal 2021 and 2022. Related amortization expense for software implementation costs was $0.1 million and $0.5 million during fiscal 2021 and 2022.
Advertising Expenses Advertising ExpensesAdvertising costs are expensed as incurred.
Stock-Based Compensation
Stock-Based Compensation
Stock-based compensation includes expenses related to restricted stock units (RSUs), performance restricted stock units (PRSUs), restricted stock, stock options and purchase rights issued to employees under our employee stock purchase plan (ESPP). RSUs, PRSUs and restricted stock are measured at the fair market value of the underlying stock at the grant date. We determine the fair value of purchase rights issued to employees under our ESPP and our stock options under our equity plans on the date of grant utilizing the Black-Scholes option pricing model, which is impacted by the fair value of our common stock, as well as changes in assumptions regarding a number of subjective variables. These variables include the expected common stock price volatility over the term of the awards, the expected term of the awards, risk-free interest rates and expected dividend yield. 
We recognize stock-based compensation expense for stock-based awards with only service conditions on a straight-line basis over the period during which an employee is required to provide services in exchange for the award (generally the vesting period of the award). We account for forfeitures as they occur. For stock-based awards granted to employees with a performance condition, we recognize stock-based compensation expense for these awards under the accelerated attribution method over the requisite service period when management determines it is probable that the performance condition will be satisfied.
Income Taxes
Income Taxes
We account for income taxes using the asset and liability method. Deferred income taxes are recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance to amounts that are more likely than not to be realized.
We recognize tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement.
Recent Accounting Pronouncements
Recent Accounting Pronouncement Not Yet Adopted
In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain convertible instruments, amends guidance on derivative scope exceptions for contracts in an entity's own equity, and modifies the guidance on diluted earnings per share (EPS) calculations as a result of these changes. The standard will be effective for us beginning February 7, 2022 and can be applied on either a fully retrospective or modified retrospective basis. We will adopt this standard in the first quarter of fiscal 2023 using the modified retrospective basis. The estimated cumulative effect of the accounting change on the Notes on February 7, 2022 will increase the carrying amount of the Notes by approximately $35.2 million, reduce accumulated deficit by approximately $98.1 million, and reduce additional paid-in capital by approximately $133.3 million. Future interest expense of the Notes will be lower as a result of adoption of this guidance and diluted net loss per share will be computed using the if-converted method for the Notes, which may be potentially dilutive.
Fair Value Measurements
Fair Value Measurements
We define fair value as the exchange price that would be received from sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Three levels of inputs may be used to measure fair value:
Level 1 - Observable inputs are unadjusted quoted prices in active markets for identical assets or liabilities;
Level 2 - Observable inputs are quoted prices for similar assets and liabilities in active markets or inputs other than quoted prices that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments; and
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on our own assumptions used to measure assets and liabilities at fair value and require significant management judgment or estimation.
v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Feb. 06, 2022
Accounting Policies [Abstract]  
Schedule of Changes in Allowance for Doubtful Accounts
The following table presents the changes in the allowance for doubtful accounts:
 
 Fiscal Year Ended
 202020212022
 (in thousands) 
Allowance for doubtful accounts, beginning balance$660 $542 $1,033 
Provision, net of cash received(80)496 (18)
Write-offs(38)(5)(70)
Allowance for doubtful accounts, ending balance$542 $1,033 $945 
v3.22.1
Financial Instruments (Tables)
12 Months Ended
Feb. 06, 2022
Investments, Debt and Equity Securities [Abstract]  
Schedule of Cash Equivalents, Marketable Securities and Restricted Cash
The following tables summarize our cash equivalents, marketable securities and restricted cash by significant investment categories and their classification within the fair value hierarchy at the end of fiscal 2021 and 2022 (in thousands):
 At the End of Fiscal 2021
 Amortized Cost Gross Unrealized GainsGross Unrealized LossesFair ValueCash EquivalentsMarketable SecuritiesRestricted Cash
Level 1    
Money market accounts$— $— $— $49,984 $39,440 $— $10,544 
Level 2    
U.S. government treasury notes339,253 3,241 (1)342,493 15,340 327,153 — 
U.S. government agencies56,729 516 — 57,245 — 57,245 — 
Corporate debt securities425,115 4,176 (33)429,258 — 429,258 — 
Foreign government bonds21,486 307 — 21,793 — 21,793 — 
Asset-backed securities79,924 1,015 — 80,939 — 80,939 — 
       Total $922,507 $9,255 $(34)$981,712 $54,780 $916,388 $10,544 
 At the End of Fiscal 2022
 Amortized Cost Gross Unrealized GainsGross Unrealized LossesFair ValueCash EquivalentsMarketable SecuritiesRestricted Cash
Level 1    
Money market accounts$— $— $— $29,275 $18,731 $— $10,544 
Level 2
U.S. government treasury notes336,303 512 (2,176)334,639 — 334,639 — 
U.S. government agencies49,153 49 (193)49,009 — 49,009 — 
Corporate debt securities491,728 384 (4,731)487,381 200 487,181 — 
Foreign government bonds12,333 37 (17)12,353 — 12,353 — 
Asset-backed securities60,361 111 (453)60,019 — 60,019 — 
Municipal bonds$3,950 $— $(78)$3,872 3,872 — 
Total$953,828 $1,093 $(7,648)$976,548 $18,931 $947,073 $10,544 
Schedule of Investments Classified by Contractual Maturity Date
The amortized cost and estimated fair value of our marketable securities are shown below by contractual maturity (in thousands):
At the End of Fiscal 2022
 Amortized CostFair Value
Due within one year$373,547 $374,017 
Due in one to five years576,151 569,216 
Due in five to ten years3,930 3,840 
  Total$953,628 $947,073 
Schedule of Unrealized Loss on Investments The following table presents gross unrealized losses and fair values for those investments that were in a continuous unrealized loss position at the end of fiscal 2021 and 2022, aggregated by investment category (in thousands):
At the End of Fiscal 2021
Less than 12 monthsGreater than 12 monthsTotal
Fair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized Loss
U.S. government treasury notes$8,301 $(1)$— $— $8,301 $(1)
Corporate debt securities32,996 (33)— — 32,996 (33)
Total$41,297 $(34)$— $— $41,297 $(34)
At the End of Fiscal 2022
Less than 12 monthsGreater than 12 monthsTotal
 Fair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized Loss
U.S. government treasury notes$193,359 $(2,176)$— $— $193,359 $(2,176)
U.S. government agencies24,388 (193)— — 24,388 (193)
Corporate debt securities 374,223 (4,708)1,182 (23)375,405 (4,731)
Foreign government bonds4,098 (17)— — 4,098 (17)
Asset-backed securities37,608 (453)— — 37,608 (453)
Municipal bonds3,872 (78)— — 3,872 (78)
     Total$637,548 $(7,625)$1,182 $(23)$638,730 $(7,648)
v3.22.1
Business Combinations (Tables)
12 Months Ended
Feb. 06, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of Consideration Transferred The total purchase consideration for the acquisition of Portworx was $352.9 million, which consisted of the following (in thousands):
Cash$344,049 
Fair value of options assumed8,802 
Total$352,851 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of the acquisition (in thousands):
AmountEstimated Useful Life
Goodwill$321,152 
Identified intangible assets:
Developed technology21,273 5 years
Customer relationships6,459 7 years
Trade name3,623 3 years
Cash4,407 
Net liabilities assumed(4,063)
Total$352,851 
v3.22.1
Balance Sheet Components (Tables)
12 Months Ended
Feb. 06, 2022
Balance Sheet Components Disclosure [Abstract]  
Schedule of Inventory Inventory consists of the following (in thousands):
At the End of Fiscal
20212022
Raw materials$4,991 $15,734 
Finished goods41,742 23,208 
Inventory$46,733 $38,942 
Schedule of Property and Equipment, Net Property and equipment, net consists of the following (in thousands):
 At the End of Fiscal
 20212022
Test equipment$238,069 $266,672 
Computer equipment and software183,763 206,053 
Furniture and fixtures8,484 8,652 
Leasehold improvements44,444 47,443 
Capitalized software development costs755 8,528 
Total property and equipment475,515 537,348 
Less: accumulated depreciation and amortization(312,474)(342,066)
Property and equipment, net$163,041 $195,282 
Schedule of Intangible Assets, Net
Intangible assets, net consist of the following (in thousands):
 
At the End of Fiscal
 20212022
 Gross Carrying ValueAccumulated AmortizationNet Carrying AmountGross Carrying ValueAccumulated AmortizationNet Carrying Amount
Technology patents$19,125 $(11,722)$7,403 $19,125 $(13,544)$5,581 
Developed technology77,373 (17,499)59,874 80,166 (30,304)49,862 
Customer relationships6,459 (308)6,151 6,459 (1,246)5,213 
Trade name3,623 (403)3,220 3,623 (1,633)1,990 
Intangible assets, net$106,580 $(29,932)$76,648 $109,373 $(46,727)$62,646 
Schedule of Expected Amortization Expenses for Intangible Assets
At the end of fiscal 2022, future expected amortization expense for intangible assets is as follows (in thousands):
Fiscal Years Ending Future Expected 
Amortization
Expense
2023$16,197 
202415,776 
202514,991 
202612,396 
20272,673 
Thereafter613 
Total$62,646 
Schedule of Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consist of the following (in thousands):
 
 At the End of Fiscal
 20212022
Taxes payable $4,097 $6,312 
Accrued marketing15,638 13,257 
Accrued cloud and outside services2,874 6,135 
Supply chain-related accruals7,461 6,991 
Accrued service logistics and professional services3,122 6,244 
Acquisition earn-out9,600 5,211 
Customer deposits from contracts with customers— 10,409 
Other accrued liabilities18,962 23,952 
Total accrued expenses and other liabilities$61,754 $78,511 
v3.22.1
Deferred Revenue and Commissions (Tables)
12 Months Ended
Feb. 06, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of Deferred Commissions
Changes in total deferred commissions during the periods presented are as follows (in thousands):
Fiscal Year Ended
20212022
Beginning balance$139,204 $187,924 
Additions183,151 217,595 
Recognition of deferred commissions(134,431)(159,212)
Ending balance$187,924 $246,307 
Schedule of Deferred Revenue
Changes in total deferred revenue during the periods presented are as follows (in thousands):
Fiscal Year Ended
20212022
Beginning balance$697,288 $843,697 
Additions703,800 937,510 
Recognition of deferred revenue(557,391)(701,335)
Ending balance $843,697 $1,079,872 
v3.22.1
Debt (Tables)
12 Months Ended
Feb. 06, 2022
Debt Disclosure [Abstract]  
Schedule of Convertible Debt
The Notes consisted of the following (in thousands):

At the End of Fiscal
20212022
Liability:
Principal$575,000 $575,000 
Less: debt discount, net of amortization(64,515)(35,641)
Less: debt issuance costs, net of amortization(4,671)(2,580)
Net carrying amount of the Notes$505,814 $536,779 
Stockholders' equity recorded at issuance:
Allocated value of the conversion feature$136,333 
Less: debt issuance costs(3,068)
Additional paid-in capital$133,265 
Schedule of Interest Expense
The following table sets forth total interest expense recognized related to the Notes (in thousands):

Fiscal Year Ended
20212022
Amortization of debt discount$26,863 $28,874 
Amortization of debt issuance costs1,944 2,091 
Total amortization of debt discount and debt issuance costs28,807 30,965 
Contractual interest expense718 732 
Total interest expense related to the Notes$29,525 $31,697 
Effective interest rate of the liability component5.6 %5.6 %
v3.22.1
Leases (Tables)
12 Months Ended
Feb. 06, 2022
Leases [Abstract]  
Components of Lease Cost
The components of lease costs were as follows (in thousands):

Fiscal Year Ended
20212022
Fixed operating lease cost$37,411 $37,598 
Variable lease cost (1)
9,168 10,228 
Short-term lease cost (12 months or less)5,734 4,178 
Total lease cost$52,313 $52,004 

(1) Variable lease cost predominantly included common area maintenance charges.
Schedule of Future Operating Lease Payments Future lease payments under our non-cancelable operating leases at the end of fiscal 2022 are as follows (in thousands):
Fiscal Years EndingOperating Leases
2023$38,627 
202433,565 
202528,980 
202620,314 
20278,266 
Thereafter17,787 
Total future lease payments$147,539 
Less: imputed interest(18,962)
Present value of lease liabilities$128,577 
v3.22.1
Stockholders' Equity (Tables)
12 Months Ended
Feb. 06, 2022
Equity [Abstract]  
Summary of Reserved Shares of Common Stock for Future Issuance
At the end of fiscal 2022, we had reserved shares of common stock for future issuance as follows:
Shares underlying outstanding stock options12,268,938 
Shares underlying outstanding restricted stock units28,712,878 
Shares reserved for future equity awards17,402,448 
Shares reserved for future employee stock purchase plan awards5,283,083 
Total63,667,347 
v3.22.1
Equity Incentive Plans (Tables)
12 Months Ended
Feb. 06, 2022
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Activity Under Equity Incentive Plans and Related Information
A summary of the stock option activity under our equity incentive plans and related information is as follows:
 
 Options Outstanding
 Number of
Shares
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
(in thousands)
Balance at the end of fiscal 202118,558,974 $9.60 4.3$251,503 
Options exercised(5,954,724)8.15   
Options forfeited/canceled(335,312)11.50   
Balance at the end of fiscal 202212,268,938 $10.25 3.5$198,266 
Vested and exercisable at the end of fiscal 202211,565,305 $10.73 3.2$180,978 
Summary of Estimate Fair Value of Employee Stock Options and Employee Purchase Plan The assumptions used for the periods presented are as follows: 
 Fiscal Year Ended
 202020212022
Employee Stock Options   
Expected term (in years)n/a5.65n/a
Expected volatilityn/a52.07%n/a
Risk-free interest raten/a0.3%n/a
Dividend raten/an/a
Fair value of common stockn/a$15.79n/a
Employee Stock Purchase Plan   
Expected term (in years)
0.5 - 2.0
0.5 - 2.0
0.5 - 2.0
Expected volatility
42% - 47%
52% - 113%
44% - 61%
Risk-free interest rate
1.7% - 2.5%
0.1% - 0.4%
0.1% - 0.2%
Dividend rate
Fair value of common stock
$17.76 - $20.87
$9.07 - $15.26
$23.63 - $26.69
Schedule of Share-based Compensation, Restricted Stock Units Award Activity A summary of the RSU and PRSU activity under our equity incentive plans and related information is as follows:
Number of RSUs and PRSUs OutstandingWeighted-Average Grant Date Fair ValueAggregate Intrinsic Value
(in thousands)
Unvested balance at the end of fiscal 202130,830,082 $15.77 $712,657 
Granted17,173,968 23.42 
Vested(12,955,468)17.07 
Forfeited(6,335,704)16.60 
Unvested balance at the end of fiscal 202228,712,878 $19.53 $757,446 
Schedule of Restricted Stock Activity A summary of the restricted stock activity under our 2015 Plan and related information is as follows:
 Number of Restricted Stock OutstandingWeighted-
Average
Grant Date
Fair Value
Aggregate
Intrinsic
Value
(in thousands)
Unvested balance at the end of fiscal 2021557,836 $19.06 $12,903 
Vested(440,687)18.78 
Forfeited(62,172)20.22 
Unvested balance at the end of fiscal 202254,977 $20.02 $1,450 
Summarizes the Components of Stock-Based Compensation
The following table summarizes the components of stock-based compensation expense recognized in the consolidated statements of operations (in thousands):
 Fiscal Year Ended
 202020212022
Cost of revenue—product$3,732 $4,001 $6,334 
Cost of revenue—subscription services14,403 14,979 21,240 
Research and development107,658 117,220 142,264 
Sales and marketing67,560 65,248 71,439 
General and administrative33,352 40,896 45,686 
Total stock-based compensation expense$226,705 $242,344 $286,963 
v3.22.1
Net Loss per Share Attributable to Common Stockholders (Tables)
12 Months Ended
Feb. 06, 2022
Earnings Per Share [Abstract]  
Summary of Computation of Basic and Diluted Net Loss per Share Attributable to Common Stockholders
The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):
 
 Fiscal Year Ended
 202020212022
 
Net loss$(200,987)$(282,076)$(143,259)
Weighted-average shares used in computing net loss
   per share attributable to common stockholders, basic and diluted
252,820 267,824 285,882 
Net loss per share attributable to common stockholders,
basic and diluted
$(0.79)$(1.05)$(0.50)
Summary of Weighted-average Outstanding Shares Excluded from Computation of Diluted Net Loss per Share Attributable to Common Stockholders
The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):
 
 Fiscal Year Ended
 202020212022
Stock options to purchase common stock31,315 23,180 15,686 
Unvested RSUs and PRSUs24,374 31,980 32,491 
Unvested restricted stock2,614 1,145 257 
Shares related to convertible senior notes21,884 21,884 21,884 
Shares issuable pursuant to the ESPP1,031 2,148 2,122 
Total81,218 80,337 72,440 
v3.22.1
Other Income (Expense), Net (Tables)
12 Months Ended
Feb. 06, 2022
Other Income and Expenses [Abstract]  
Schedule of Interest and Other Income
Other income (expense), net consists of the following (in thousands):
Fiscal Year Ended
202020212022
Interest income (1)
$27,241 $17,442 $9,371 
Interest expense (2)
(27,897)(31,403)(36,677)
Foreign currency transactions (losses) gains(3,396)2,507 (5,235)
Other income669 2,327 2,443 
Total other income (expense), net$(3,383)$(9,127)$(30,098)
_________________________________
(1) Interest income includes interest income related to our cash, cash equivalents and marketable securities and non-cash interest income (expense) related to accretion (amortization) of the discount (premium) on marketable securities.
(2) Interest expense includes non-cash interest expense related to amortization of the debt discount and debt issuance costs and the contractual interest expense related to our debt.
v3.22.1
Income Taxes (Tables)
12 Months Ended
Feb. 06, 2022
Income Tax Disclosure [Abstract]  
Schedule Of Geographical Breakdown Of Loss Before Provision For Income Taxes
The geographical breakdown of loss before provision for income taxes is as follows (in thousands):

 Fiscal Year Ended
 202020212022
Domestic$(212,672)$(312,119)$(192,058)
International18,006 41,959 63,562 
Total$(194,666)$(270,160)$(128,496)
Schedule of Components of Provision for Income Taxes
The components of the provision for income taxes are as follows (in thousands):

 Fiscal Year Ended
 202020212022
Current:   
State$538 $442 $592 
Foreign7,774 8,006 12,525 
Total$8,312 $8,448 $13,117 
Deferred:   
Federal$(1,559)$(218)$— 
State(198)— — 
Foreign(234)3,686 1,646 
Total$(1,991)$3,468 $1,646 
Provision for income taxes$6,321 $11,916 $14,763 
Schedule of Reconciliation of the Federal Statutory Income Tax Rate and Effective Income Tax Rate
The reconciliation of income taxes at the federal statutory income tax rate to the provision for income taxes is as follows (in thousands):
 Fiscal Year Ended
 202020212022
Tax at federal statutory rate$(40,880)$(56,734)$(26,984)
State tax, net of federal benefit210 349 468 
Stock-based compensation expense(6,683)(604)(19,658)
Research and development tax credits(11,033)(14,138)(16,783)
U.S. taxes on foreign income— 14,021 25,059 
Foreign rate differential2,935 2,282 (1,698)
Change in valuation allowance61,050 63,146 48,270 
Non-deductible expenses— — 4,381 
Other722 3,594 1,708 
Provision for income taxes$6,321 $11,916 $14,763 
Significant Components of Deferred Tax Assets and Liabilities The significant components of our deferred tax assets and liabilities were as follows (in thousands):
 At the End of Fiscal
 20212022
Deferred tax assets:  
Net operating loss carryforwards$308,250 $369,904 
Tax credit carryover104,247 134,085 
Accruals and reserves22,263 22,625 
Deferred revenue69,886 66,242 
Stock-based compensation expense28,310 25,247 
Depreciation and amortization120 — 
Charitable contribution carryforwards229 290 
Interest expense limitation (163(j))110 — 
ASC 842 lease liabilities33,302 28,577 
Other— 1,589 
Total deferred tax assets$566,717 $648,559 
Valuation allowance(484,437)(554,553)
Total deferred tax assets, net of valuation allowance$82,280 $94,006 
Deferred tax liabilities:  
Depreciation and amortization$— $(12,992)
Deferred commissions(41,526)(53,219)
Convertible debt(8,147)(4,642)
ASC 842 right-of-use assets(29,183)(24,608)
Acquired intangibles and goodwill(8,727)(6,850)
Intercompany interest— (874)
Other(2,230)— 
Total deferred tax liabilities$(89,813)$(103,185)
Net deferred tax liabilities$(7,533)$(9,179)
Summary of Activity Related to Unrecognized Tax Benefits
The activity related to the unrecognized tax benefits is as follows (in thousands):
 Fiscal Year Ended
 202020212022
Gross unrecognized tax benefits—beginning balance$18,891 $28,570 $39,571 
Decreases related to tax positions taken during prior years(34)(345)(173)
Increases related to tax positions taken during prior years408 1,881 1,201 
Increases related to tax positions taken during current year
9,305 9,465 10,983 
Gross unrecognized tax benefits—ending balance$28,570 $39,571 $51,582 
v3.22.1
Segment Information (Tables)
12 Months Ended
Feb. 06, 2022
Segment Reporting [Abstract]  
Schedule of Revenue by Geographic Area
The following table depicts the disaggregation of revenue by geographic area based on the billing address of our customers and is consistent with how we evaluate our financial performance (in thousands):
 
 Fiscal Year Ended
 202020212022
United States$1,184,923 $1,195,428 $1,580,022 
Rest of the world458,517 488,751 600,826 
Total revenue$1,643,440 $1,684,179 $2,180,848 
Schedule of Long-Lived Assets by Geographic Area
Long-lived assets, which are comprised of property and equipment, net, by geographic area are summarized as follows (in thousands):
 At the End of Fiscal
 20212022
United States$152,859 $187,228 
Rest of the world10,182 8,054 
Total long-lived assets$163,041 $195,282 
v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)
3 Months Ended 12 Months Ended
Feb. 07, 2022
USD ($)
May 02, 2021
Feb. 06, 2022
USD ($)
revenueSource
Jan. 31, 2021
USD ($)
revenueSource
Feb. 02, 2020
USD ($)
Concentration Risk [Line Items]          
Number of financial institutions where deposits exceed federally insured limits | revenueSource     3 3  
Restricted cash     $ 10,544,000 $ 10,544,000 $ 15,287,000
Depreciation and amortization     83,151,000 70,042,000 89,710,000
Impairment of goodwill     $ 0 0  
Useful life of deferred commissions related to subscription services revenue     6 years    
Number of revenue sources | revenueSource     2    
Capitalized software, amortization     $ 500,000 100,000  
Advertising expenses     15,300,000 8,100,000 $ 13,300,000
Accumulated deficit     1,708,271,000 1,565,012,000  
Property, Plant and Equipment          
Concentration Risk [Line Items]          
Software development costs capitalized during the period     7,800,000 700,000  
Other Assets          
Concentration Risk [Line Items]          
Software development costs capitalized during the period     $ 3,500,000 $ 1,900,000  
Subsequent Event          
Concentration Risk [Line Items]          
Debt instrument increase net $ 35,200,000        
Accumulated deficit 98,100,000        
Reduce in additional paid-in capital $ 133,300,000        
Hardware          
Concentration Risk [Line Items]          
Standard product warranty period     3 years    
Embedded Software          
Concentration Risk [Line Items]          
Standard product warranty period     90 days    
Change in accounting estimate          
Concentration Risk [Line Items]          
Depreciation and amortization     $ (23,600,000)    
Minimum          
Concentration Risk [Line Items]          
Estimated useful life of intangible assets     3 years    
Maximum          
Concentration Risk [Line Items]          
Estimated useful life of intangible assets     7 years    
Test equipment          
Concentration Risk [Line Items]          
Property and equipment, useful life     4 years    
Computer equipment and software          
Concentration Risk [Line Items]          
Property and equipment, useful life     4 years    
Computer equipment and software | Minimum          
Concentration Risk [Line Items]          
Property and equipment, useful life     2 years    
Computer equipment and software | Maximum          
Concentration Risk [Line Items]          
Property and equipment, useful life       3 years  
Furniture and fixtures          
Concentration Risk [Line Items]          
Property and equipment, useful life     7 years    
Test equipment, certain computer equipment and software          
Concentration Risk [Line Items]          
Property and equipment, useful life   4 years      
Software development costs          
Concentration Risk [Line Items]          
Property and equipment, useful life     4 years    
Customer concentration risk | Accounts receivable | 1 Customer          
Concentration Risk [Line Items]          
Concentration risk percentage     1000.00%    
Customer concentration risk | Accounts receivable | 1 Channel Partner          
Concentration Risk [Line Items]          
Concentration risk percentage     1000.00%    
Customer concentration risk | Revenue | No Channel Partner or Customer          
Concentration Risk [Line Items]          
Concentration risk percentage     1000.00% 1000.00% 1000.00%
v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Changes in Allowance for Doubtful Accounts (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Allowance for Doubtful Accounts Receivable [Roll Forward]      
Allowance for doubtful accounts, beginning balance $ 1,033 $ 542 $ 660
Provision, net of cash received (18) 496 (80)
Write-offs (70) (5) (38)
Allowance for doubtful accounts, ending balance $ 945 $ 1,033 $ 542
v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies - Revenue Recognition (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-02-07
Feb. 06, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue contractual term 12 months
Subscription Service Revenue | Minimum  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue contractual term 1 year
Subscription Service Revenue | Maximum  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue contractual term 6 years
v3.22.1
Financial Instruments - Cash Equivalents, Marketable Securities and Restricted Cash (Details) - USD ($)
$ in Thousands
Feb. 06, 2022
Jan. 31, 2021
Debt Securities, Available-for-sale [Line Items]    
Fair Value $ 947,073  
Cash Equivalents 18,931 $ 54,780
Marketable securities 947,073 916,388
Restricted Cash 10,544 10,544
Amortized Cost 953,828 922,507
Total gross unrealized gains 1,093 9,255
Total gross unrealized losses (7,648) (34)
Total fair value 976,548 981,712
Fair Value, Less then 12 months 637,548 41,297
Unrealized Loss, Less then 12 months (7,625) (34)
Fair Value Greater then 12 months 1,182 0
Unrealized Loss, Greater then 12 months (23) 0
U.S. government treasury notes    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 193,359 8,301
Unrealized Loss, Less then 12 months (2,176) (1)
Fair Value Greater then 12 months 0 0
Unrealized Loss, Greater then 12 months 0 0
U.S. government agencies    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 24,388  
Unrealized Loss, Less then 12 months (193)  
Fair Value Greater then 12 months 0  
Unrealized Loss, Greater then 12 months 0  
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 374,223 32,996
Unrealized Loss, Less then 12 months (4,708) (33)
Fair Value Greater then 12 months 1,182 0
Unrealized Loss, Greater then 12 months (23) 0
Foreign government bonds    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 4,098  
Unrealized Loss, Less then 12 months (17)  
Fair Value Greater then 12 months 0  
Unrealized Loss, Greater then 12 months 0  
Asset-backed securities    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 37,608  
Unrealized Loss, Less then 12 months (453)  
Fair Value Greater then 12 months 0  
Unrealized Loss, Greater then 12 months 0  
Municipal bonds    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 3,872  
Unrealized Loss, Less then 12 months (78)  
Fair Value Greater then 12 months 0  
Unrealized Loss, Greater then 12 months 0  
Level 1 | Money market accounts    
Debt Securities, Available-for-sale [Line Items]    
Fair Value 29,275 49,984
Cash Equivalents 18,731 39,440
Marketable securities 0 0
Restricted Cash 10,544 10,544
Level 2 | U.S. government treasury notes    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 336,303 339,253
Gross Unrealized Gains 512 3,241
Gross Unrealized Losses (2,176) (1)
Fair Value 334,639 342,493
Cash Equivalents 0 15,340
Marketable securities 334,639 327,153
Restricted Cash 0 0
Level 2 | U.S. government agencies    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 49,153 56,729
Gross Unrealized Gains 49 516
Gross Unrealized Losses (193) 0
Fair Value 49,009 57,245
Cash Equivalents 0 0
Marketable securities 49,009 57,245
Restricted Cash 0 0
Level 2 | Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 491,728 425,115
Gross Unrealized Gains 384 4,176
Gross Unrealized Losses (4,731) (33)
Fair Value 487,381 429,258
Cash Equivalents 200 0
Marketable securities 487,181 429,258
Restricted Cash 0 0
Level 2 | Foreign government bonds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 12,333 21,486
Gross Unrealized Gains 37 307
Gross Unrealized Losses (17) 0
Fair Value 12,353 21,793
Cash Equivalents 0 0
Marketable securities 12,353 21,793
Restricted Cash 0 0
Level 2 | Asset-backed securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 60,361 79,924
Gross Unrealized Gains 111 1,015
Gross Unrealized Losses (453) 0
Fair Value 60,019 80,939
Cash Equivalents 0 0
Marketable securities 60,019 80,939
Restricted Cash 0 $ 0
Level 2 | Municipal bonds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 3,950  
Gross Unrealized Gains 0  
Gross Unrealized Losses (78)  
Fair Value 3,872  
Cash Equivalents  
Marketable securities 3,872  
Restricted Cash $ 0  
v3.22.1
Financial Instruments - Amortized Cost and Estimated Fair Value (Details) - USD ($)
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Amortized Cost      
Due within one year $ 373,547,000    
Due in one to five years 576,151,000    
Due in five to ten years 3,930,000    
Total 953,628,000    
Fair Value Disclosures [Abstract]      
Due within one year 374,017,000    
Due in one to five years 569,216,000    
Due in five to ten years 3,840,000    
Total 947,073,000    
Impairment charge for unrealized losses $ 0 $ 0 $ 0
v3.22.1
Financial Instruments - Gross Unrealized Losses and Fair Values (Details) - USD ($)
$ in Thousands
Feb. 06, 2022
Jan. 31, 2021
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months $ 637,548 $ 41,297
Unrealized Loss, Less then 12 months (7,625) (34)
Fair Value Greater then 12 months 1,182 0
Unrealized Loss, Greater then 12 months (23) 0
Fair Value Total 638,730 41,297
Unrealized Loss Total (7,648) (34)
U.S. government treasury notes    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 193,359 8,301
Unrealized Loss, Less then 12 months (2,176) (1)
Fair Value Greater then 12 months 0 0
Unrealized Loss, Greater then 12 months 0 0
Fair Value Total 193,359 8,301
Unrealized Loss Total (2,176) (1)
U.S. government agencies    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 24,388  
Unrealized Loss, Less then 12 months (193)  
Fair Value Greater then 12 months 0  
Unrealized Loss, Greater then 12 months 0  
Fair Value Total 24,388  
Unrealized Loss Total (193)  
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 374,223 32,996
Unrealized Loss, Less then 12 months (4,708) (33)
Fair Value Greater then 12 months 1,182 0
Unrealized Loss, Greater then 12 months (23) 0
Fair Value Total 375,405 32,996
Unrealized Loss Total (4,731) $ (33)
Foreign government bonds    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 4,098  
Unrealized Loss, Less then 12 months (17)  
Fair Value Greater then 12 months 0  
Unrealized Loss, Greater then 12 months 0  
Fair Value Total 4,098  
Unrealized Loss Total (17)  
Asset-backed securities    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 37,608  
Unrealized Loss, Less then 12 months (453)  
Fair Value Greater then 12 months 0  
Unrealized Loss, Greater then 12 months 0  
Fair Value Total 37,608  
Unrealized Loss Total (453)  
Municipal bonds    
Debt Securities, Available-for-sale [Line Items]    
Fair Value, Less then 12 months 3,872  
Unrealized Loss, Less then 12 months (78)  
Fair Value Greater then 12 months 0  
Unrealized Loss, Greater then 12 months 0  
Fair Value Total 3,872  
Unrealized Loss Total $ (78)  
v3.22.1
Business Combinations - Additional Information (Details) - USD ($)
shares in Millions
1 Months Ended 12 Months Ended
Oct. 31, 2020
Jun. 30, 2019
Apr. 30, 2019
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Business Acquisition [Line Items]            
Purchase consideration, net of cash acquired       $ 0 $ 339,641,000 $ 51,594,000
Goodwill       $ 358,736,000 $ 358,736,000  
Developed technology            
Business Acquisition [Line Items]            
Finite-lived intangibles acquired, amortization period       3 years 10 months 24 days    
Portworx            
Business Acquisition [Line Items]            
Total purchase consideration $ 352,851,000          
Goodwill expected to be tax deductible 0          
Deferred tax assets, before valuation allowance 14,700,000          
Deferred tax assets, valuation allowance 14,700,000          
Deferred tax assets, net 0          
Transaction price contingent on continuous employment of founders $ 32,200,000     $ 13,500,000    
Transaction price contingent on continuous employment of founders, earnout period 3 years          
Goodwill $ 321,152,000          
Net liabilities assumed $ 4,063,000          
Portworx | Replacement Awards            
Business Acquisition [Line Items]            
Shares issued upon conversion of stock options (in shares) 1.9          
Equity interests issued and issuable $ 26,800,000          
Portworx | Replacement Awards for Services Performed Prior to the Acquisition            
Business Acquisition [Line Items]            
Equity interests issued and issuable 8,800,000          
Portworx | Replacement Awards for Future Services            
Business Acquisition [Line Items]            
Equity interests issued and issuable 18,000,000          
Portworx | Unvested RSUs and PRSUs            
Business Acquisition [Line Items]            
Equity interests issued and issuable $ 31,800,000          
Outstanding awards assumed (in shares) 2.0          
Equity awards vesting period 4 years          
Portworx | Developed technology            
Business Acquisition [Line Items]            
Identified intangible assets: $ 21,273,000          
Finite-lived intangibles acquired, amortization period 5 years          
Compuverde AB            
Business Acquisition [Line Items]            
Purchase consideration, net of cash acquired     $ 47,900,000      
Long-term debt assumed and subsequently paid off     11,600,000      
Goodwill     26,600,000      
Net liabilities assumed     11,700,000      
Deferred tax liabilities assumed     5,400,000      
Consideration to be transferred       $ 15,900,000    
Term of payments       2 years    
Compuverde AB | Unvested RSUs and PRSUs            
Business Acquisition [Line Items]            
Equity interests issued and issuable   $ 3,000,000        
Compuverde AB | Developed technology            
Business Acquisition [Line Items]            
Identified intangible assets:     $ 38,400,000      
Finite-lived intangibles acquired, amortization period     7 years      
v3.22.1
Business Combinations - Purchase Consideration (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Oct. 31, 2020
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Business Acquisition [Line Items]        
Fair value of options assumed   $ 0 $ 8,802 $ 0
Portworx        
Business Acquisition [Line Items]        
Cash $ 344,049      
Fair value of options assumed 8,802      
Total $ 352,851      
v3.22.1
Business Combinations - Net Assets Acquired (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Oct. 31, 2020
Feb. 06, 2022
Jan. 31, 2021
Business Acquisition [Line Items]      
Goodwill   $ 358,736 $ 358,736
Developed technology      
Business Acquisition [Line Items]      
Estimated Useful Life   3 years 10 months 24 days  
Customer relationships      
Business Acquisition [Line Items]      
Estimated Useful Life   5 years 7 months 6 days  
Trade name      
Business Acquisition [Line Items]      
Estimated Useful Life   1 year 7 months 6 days  
Portworx      
Business Acquisition [Line Items]      
Goodwill $ 321,152    
Cash 4,407    
Net liabilities assumed (4,063)    
Total 352,851    
Portworx | Developed technology      
Business Acquisition [Line Items]      
Identified intangible assets: $ 21,273    
Estimated Useful Life 5 years    
Portworx | Customer relationships      
Business Acquisition [Line Items]      
Identified intangible assets: $ 6,459    
Estimated Useful Life 7 years    
Portworx | Trade name      
Business Acquisition [Line Items]      
Identified intangible assets: $ 3,623    
Estimated Useful Life 3 years    
v3.22.1
Balance Sheet Components - Inventory (Details) - USD ($)
$ in Thousands
Feb. 06, 2022
Jan. 31, 2021
Balance Sheet Components Disclosure [Abstract]    
Raw materials $ 15,734 $ 4,991
Finished goods 23,208 41,742
Inventory $ 38,942 $ 46,733
v3.22.1
Balance Sheet Components - Property and Equipment, Net (Details) - USD ($)
$ in Thousands
Feb. 06, 2022
Jan. 31, 2021
Property Plant And Equipment [Line Items]    
Total property and equipment $ 537,348 $ 475,515
Less: accumulated depreciation and amortization (342,066) (312,474)
Property and equipment, net 195,282 163,041
Test equipment    
Property Plant And Equipment [Line Items]    
Total property and equipment 266,672 238,069
Computer equipment and software    
Property Plant And Equipment [Line Items]    
Total property and equipment 206,053 183,763
Furniture and fixtures    
Property Plant And Equipment [Line Items]    
Total property and equipment 8,652 8,484
Leasehold improvements    
Property Plant And Equipment [Line Items]    
Total property and equipment 47,443 44,444
Capitalized software development costs    
Property Plant And Equipment [Line Items]    
Total property and equipment $ 8,528 $ 755
v3.22.1
Balance Sheet Components - Additional Information (Details) - USD ($)
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Finite Lived Intangible Assets [Line Items]      
Depreciation and amortization $ 65,900,000 $ 57,100,000 $ 80,400,000
Intangible assets amortization expense 16,800,000 13,000,000 $ 9,300,000
Goodwill 358,736,000 358,736,000  
Impairment of goodwill $ 0 $ 0  
Technology patents      
Finite Lived Intangible Assets [Line Items]      
Estimated Useful Life 2 years    
Developed technology      
Finite Lived Intangible Assets [Line Items]      
Estimated Useful Life 3 years 10 months 24 days    
Customer relationships      
Finite Lived Intangible Assets [Line Items]      
Estimated Useful Life 5 years 7 months 6 days    
Trade name      
Finite Lived Intangible Assets [Line Items]      
Estimated Useful Life 1 year 7 months 6 days    
v3.22.1
Balance Sheet Components - Intangible Assets, Net (Details) - USD ($)
$ in Thousands
Feb. 06, 2022
Jan. 31, 2021
Finite Lived Intangible Assets [Line Items]    
Gross Carrying Value $ 109,373 $ 106,580
Accumulated Amortization (46,727) (29,932)
Net Carrying Amount 62,646 76,648
Technology patents    
Finite Lived Intangible Assets [Line Items]    
Gross Carrying Value 19,125 19,125
Accumulated Amortization (13,544) (11,722)
Net Carrying Amount 5,581 7,403
Developed technology    
Finite Lived Intangible Assets [Line Items]    
Gross Carrying Value 80,166 77,373
Accumulated Amortization (30,304) (17,499)
Net Carrying Amount 49,862 59,874
Customer relationships    
Finite Lived Intangible Assets [Line Items]    
Gross Carrying Value 6,459 6,459
Accumulated Amortization (1,246) (308)
Net Carrying Amount 5,213 6,151
Trade name    
Finite Lived Intangible Assets [Line Items]    
Gross Carrying Value 3,623 3,623
Accumulated Amortization (1,633) (403)
Net Carrying Amount $ 1,990 $ 3,220
v3.22.1
Balance Sheet Components - Expected Amortization Expenses for Intangible Assets (Details) - USD ($)
$ in Thousands
Feb. 06, 2022
Jan. 31, 2021
Balance Sheet Components Disclosure [Abstract]    
2023 $ 16,197  
2024 15,776  
2025 14,991  
2026 12,396  
2027 2,673  
Thereafter 613  
Net Carrying Amount $ 62,646 $ 76,648
v3.22.1
Balance Sheet Components - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($)
$ in Thousands
Feb. 06, 2022
Jan. 31, 2021
Balance Sheet Components Disclosure [Abstract]    
Taxes payable $ 6,312 $ 4,097
Accrued marketing 13,257 15,638
Accrued cloud and outside services 6,135 2,874
Supply chain-related accruals 6,991 7,461
Accrued service logistics and professional services 6,244 3,122
Acquisition earn-out 5,211 9,600
Customer deposits from contracts with customers 10,409 0
Other accrued liabilities 23,952 18,962
Accrued expenses and other liabilities $ 78,511 $ 61,754
v3.22.1
Deferred Revenue and Commissions - Deferred Commissions (Details) - USD ($)
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Deferred Commissions [Roll Forward]      
Beginning balance $ 187,924,000 $ 139,204,000  
Additions 217,595,000 183,151,000  
Recognition of deferred commissions (159,212,000) (134,431,000)  
Ending balance 246,307,000 187,924,000 $ 139,204,000
Sales commission expenses $ 175,900,000 150,200,000 142,500,000
Commissions expected to be recognized over the next 12 months 33.00%    
Impairment of capitalized commissions $ 0 $ 0 $ 0
v3.22.1
Deferred Revenue and Commissions - Deferred Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Disaggregation of Revenue [Line Items]    
Additions $ 217,595 $ 183,151
Recognition of deferred commissions (159,212) (134,431)
Product Revenue and Support Subscription Revenue    
Disaggregation of Revenue [Line Items]    
Beginning balance 843,697 697,288
Additions 937,510 703,800
Recognition of deferred commissions (701,335) (557,391)
Ending balance $ 1,079,872 $ 843,697
v3.22.1
Deferred Revenue and Commissions - Remaining Performance Obligations (Details) - USD ($)
$ in Millions
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Revenue from Contract with Customer [Abstract]    
Revenue pertaining to deferred revenue recognized in period $ 442.7 $ 353.1
Contracted but not recognized revenue $ 1,400.0  
Performance obligation expected to be recognized as revenue in the next 12 months (percent) 47.00%  
v3.22.1
Deferred Revenue and Commissions - Remaining Performance Obligation Period (Details)
Feb. 06, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-02-07  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue contractual term 12 months
v3.22.1
Debt - Additional Information (Details)
1 Months Ended 12 Months Ended
Feb. 28, 2022
USD ($)
Aug. 31, 2020
USD ($)
Apr. 30, 2018
USD ($)
day
shares
$ / shares
Feb. 06, 2022
USD ($)
financial_ratio
$ / shares
Jan. 31, 2021
USD ($)
Feb. 02, 2020
USD ($)
Sep. 30, 2020
USD ($)
Apr. 04, 2018
$ / shares
Debt Instrument [Line Items]                
Proceeds from issuance of convertible debt       $ 0 $ 251,892,000 $ 0    
Debt issuance costs, net of amortization     $ 12,900,000          
Closing price of stock (in dollars per share) | $ / shares       $ 26.38        
Revolving Credit Facility                
Debt Instrument [Line Items]                
Debt instrument, term   5 years            
Senior secured credit facility, maximum borrowing capacity   $ 300,000,000            
Credit facility, maturity period prior to stated maturity if out of compliance with liquidity threshold   91 days            
Credit facility, daily minimum sum of cash and cash equivalents and aggregate unused commitments to prevent maturity prior to stated maturity   $ 625,000,000            
Credit facility, amount borrowed             $ 250,000,000  
Interest expense       $ 4,100,000 $ 1,400,000      
Number of financial ratios | financial_ratio       2        
Maximum consolidation leverage ratio       4.5        
Minimum interest coverage ratio       3        
Revolving Credit Facility | Subsequent Event                
Debt Instrument [Line Items]                
Repayments of long-term lines of credit $ 250,000,000              
Revolving Credit Facility | London Interbank Offered Rate (LIBOR)                
Debt Instrument [Line Items]                
Interest rate during the period (percent)       1.60% 1.65%      
Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Interest Rate Floor                
Debt Instrument [Line Items]                
Effective interest rate (percent)   0.00%            
Revolving Credit Facility | Minimum                
Debt Instrument [Line Items]                
Commitment fee (percent)   0.25%            
Revolving Credit Facility | Minimum | Base Rate                
Debt Instrument [Line Items]                
Margin rate (percent)   0.50%            
Revolving Credit Facility | Minimum | London Interbank Offered Rate (LIBOR)                
Debt Instrument [Line Items]                
Margin rate (percent)   1.50%            
Revolving Credit Facility | Maximum                
Debt Instrument [Line Items]                
Commitment fee (percent)   0.40%            
Revolving Credit Facility | Maximum | Base Rate                
Debt Instrument [Line Items]                
Margin rate (percent)   1.25%            
Revolving Credit Facility | Maximum | London Interbank Offered Rate (LIBOR)                
Debt Instrument [Line Items]                
Margin rate (percent)   2.25%            
Capped Call                
Debt Instrument [Line Items]                
Payment to enter into agreement     64,600,000          
Convertible Senior Notes                
Debt Instrument [Line Items]                
Debt issuance costs, net of amortization     9,800,000 $ 2,580,000 $ 4,671,000      
Additional Paid-In Capital                
Debt Instrument [Line Items]                
Debt issuance costs, net of amortization     $ 3,100,000 $ 3,068,000        
Common stock                
Debt Instrument [Line Items]                
Conversion price (in dollars per share) | $ / shares     $ 26.27          
Closing price of stock (in dollars per share) | $ / shares       $ 26.38        
Common stock | Capped Call                
Debt Instrument [Line Items]                
Exercise price (in dollars per share) | $ / shares     $ 39.66         $ 39.66
Exercise price premium percentage over last reported sales price               100.00%
Convertible Senior Notes                
Debt Instrument [Line Items]                
Principal amount     $ 575,000,000          
Interest rate ( as a percent)     0.125%          
Proceeds from issuance of convertible debt     $ 562,100,000          
Conversion percentage of principal amount plus accrued and unpaid contingent interest     100.00%          
Redemption percentage of principal amount of Notes to be redeemed     100.00%          
Convertible debt, fair value based on the closing trading price per $100 of the Notes       $ 681,800,000 649,000,000      
If-converted value       $ 577,300,000        
Remaining term of the notes       14 months        
Interest expense       $ 31,697,000 $ 29,525,000      
Convertible Senior Notes | Any Fiscal Quarter Commencing After the Fiscal Quarter Ending on July 31, 2018                
Debt Instrument [Line Items]                
Threshold percentage of stock price trigger     130.00%          
Convertible Senior Notes | Common stock                
Debt Instrument [Line Items]                
Number of convertible shares at initial conversion rate (in shares) | shares     21,884,155          
Conversion ratio (in shares per $1,000 principal amount)     38.0594          
Conversion price (in dollars per share) | $ / shares     $ 26.27          
Convertible Senior Notes | Common stock | Any Fiscal Quarter Commencing After the Fiscal Quarter Ending on July 31, 2018                
Debt Instrument [Line Items]                
Threshold trading days | day     20          
Threshold consecutive trading days | day     30          
Threshold percentage of stock price trigger     130.00%          
Convertible Senior Notes | Common stock | Five Business Day Period After any Five Consecutive Trading Day Period                
Debt Instrument [Line Items]                
Threshold consecutive trading days | day     5          
Threshold percentage of stock price trigger     98.00%          
Threshold business days | day     5          
Convertible Senior Notes | Common stock | Immediately Preceding the Date on Which We Provide Notice of Redemption                
Debt Instrument [Line Items]                
Threshold trading days | day     2          
v3.22.1
Debt - Convertible Debt (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Apr. 30, 2018
Liability:      
Less: debt issuance costs, net of amortization     $ (12,900)
Stockholders' equity recorded at issuance:      
Less: debt issuance costs     (12,900)
Convertible Senior Notes      
Liability:      
Principal $ 575,000 $ 575,000  
Less: debt discount, net of amortization (35,641) (64,515)  
Less: debt issuance costs, net of amortization (2,580) (4,671) (9,800)
Net carrying amount of the Notes 536,779 505,814  
Stockholders' equity recorded at issuance:      
Less: debt issuance costs (2,580) $ (4,671) (9,800)
Additional Paid-In Capital      
Liability:      
Less: debt issuance costs, net of amortization (3,068)   (3,100)
Stockholders' equity recorded at issuance:      
Allocated value of the conversion feature 136,333    
Less: debt issuance costs (3,068)   $ (3,100)
Additional paid-in capital $ 133,265    
v3.22.1
Debt - Interest Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Debt Instrument [Line Items]      
Total amortization of debt discount and debt issuance costs $ 31,577 $ 29,070 $ 27,179
Convertible Senior Notes      
Debt Instrument [Line Items]      
Amortization of debt discount 28,874 26,863  
Amortization of debt issuance costs 2,091 1,944  
Total amortization of debt discount and debt issuance costs 30,965 28,807  
Contractual interest expense 732 718  
Total interest expense related to the Notes $ 31,697 $ 29,525  
Effective interest rate of the liability component ( as a percent) 5.60% 5.60%  
v3.22.1
Commitments and Contingencies - (Details) - USD ($)
Feb. 06, 2022
Jan. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Non-cancelable purchase obligations $ 289,000,000  
Outstanding letters of credit 6,700,000 $ 6,700,000
Loss contingency $ 0  
v3.22.1
Leases - Lease costs (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Leases [Abstract]    
Fixed operating lease cost $ 37,598 $ 37,411
Variable lease cost 10,228 9,168
Short-term lease cost (12 months or less) 4,178 5,734
Total lease cost $ 52,004 $ 52,313
v3.22.1
Leases - Additional Information (Details)
Feb. 06, 2022
Jan. 31, 2021
Leases [Abstract]    
Operating lease, weighted average remaining lease term 4 years 6 months 5 years 2 months 12 days
Operating lease, weighted average discount rate (percent) 5.70% 5.80%
v3.22.1
Leases - Future lease payments under noncancelable leases (Details)
$ in Thousands
Feb. 06, 2022
USD ($)
Leases [Abstract]  
2023 $ 38,627
2024 33,565
2025 28,980
2026 20,314
2027 8,266
Thereafter 17,787
Total future lease payments 147,539
Less: imputed interest (18,962)
Present value of lease liabilities $ 128,577
v3.22.1
Restructuring and Other (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Restructuring Cost and Reserve [Line Items]    
Lease liabilities $ 128,577  
Restructuring liability 0  
COVID-19 Pandemic Costs    
Restructuring Cost and Reserve [Line Items]    
Restructuring and other   $ 9,800
COVID-19 Pandemic Costs | Restructuring Charges    
Restructuring Cost and Reserve [Line Items]    
Restructuring and other   8,900
COVID-19 Pandemic Costs | Cost of Revenue    
Restructuring Cost and Reserve [Line Items]    
Restructuring and other   900
Ceased Use of Certain Leased Facilities    
Restructuring Cost and Reserve [Line Items]    
Impairment charge 7,500  
Lease liabilities $ 2,400  
One-time Involuntary Termination Benefits | Restructuring Charges    
Restructuring Cost and Reserve [Line Items]    
Restructuring and other   $ 12,200
v3.22.1
Stockholders' Equity - Additional Information (Details)
12 Months Ended
Feb. 06, 2022
USD ($)
stock_class
$ / shares
shares
Jan. 31, 2021
USD ($)
$ / shares
shares
Feb. 02, 2020
USD ($)
$ / shares
shares
Apr. 04, 2022
USD ($)
Mar. 31, 2022
USD ($)
Feb. 28, 2021
USD ($)
Aug. 31, 2019
USD ($)
Class of Stock [Line Items]              
Preferred stock, shares authorized (in shares) 20,000,000 20,000,000          
Preferred stock, shares issued (in shares) 0 0          
Preferred stock, shares outstanding (in shares) 0 0          
Number of classes of stock | stock_class 2            
Common stock, shares authorized (in shares) 2,250,000,000 2,250,000,000          
Subsequent Event              
Class of Stock [Line Items]              
Value approved for repurchase | $         $ 250,000,000    
Remaining authorized repurchase amount | $       $ 231,900,000      
Class A common stock              
Class of Stock [Line Items]              
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000          
Common stock, par value per share (in dollars per share) | $ / shares $ 0.0001 $ 0.0001          
Common stock, shares issued (in shares) 292,632,893 278,363,000          
Common stock, shares outstanding (in shares) 292,632,893 278,363,000          
Value approved for repurchase | $           $ 200,000,000 $ 150,000,000
Stock repurchased and retired (in shares) 8,489,168 9,526,556 867,657        
Stock repurchased and retired, average cost (in dollars per share) | $ / shares $ 23.56 $ 14.17 $ 17.29        
Stock repurchased and retired, value | $ $ 200,000,000 $ 135,000,000 $ 15,000,000        
Class B common stock              
Class of Stock [Line Items]              
Common stock, shares authorized (in shares) 250,000,000 250,000,000          
Common stock, par value per share (in dollars per share) | $ / shares $ 0.0001 $ 0.0001          
v3.22.1
Stockholders' Equity - Summary of Reserved Shares of Common Stock for Future Issuance (Details) - shares
Feb. 06, 2022
Jan. 31, 2021
Class of Stock [Line Items]    
Shares underlying outstanding equity awards (in shares) 12,268,938 18,558,974
Shares reserved for future equity awards (in shares) 63,667,347  
Employee stock purchase plan    
Class of Stock [Line Items]    
Shares reserved for future equity awards (in shares) 5,283,083  
Unvested RSUs and PRSUs    
Class of Stock [Line Items]    
Shares underlying outstanding equity awards (in shares) 28,712,878  
Employee Stock Options    
Class of Stock [Line Items]    
Shares reserved for future equity awards (in shares) 17,402,448  
v3.22.1
Equity Incentive Plans - Additional Information (Details)
1 Months Ended 12 Months Ended
Feb. 28, 2019
USD ($)
Feb. 06, 2022
USD ($)
period
plan
$ / shares
shares
Jan. 31, 2021
USD ($)
Feb. 02, 2020
USD ($)
Jan. 31, 2017
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Number of equity incentive plans | plan   2      
Shares reserved for future equity awards (in shares) | shares   63,667,347      
Total stock-based compensation expense   $ 286,963,000 $ 242,344,000 $ 226,705,000  
Closing price of stock (in dollars per share) | $ / shares   $ 26.38      
Stock options to purchase common stock          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Shares reserved for future equity awards (in shares) | shares   17,402,448      
Total stock-based compensation expense   $ 7,700,000 8,600,000 15,800,000  
Unrecognized compensation cost related to stock awards, weighted-average period   1 year 7 months 6 days      
Intrinsic value of exercised options   $ 105,100,000 118,800,000 106,600,000  
Total grant date fair value of options vested   16,500,000 $ 20,100,000 $ 34,200,000  
Unrecognized compensation cost   $ 7,500,000      
Dividend rate     0.00%    
Employee Stock Purchase Plan          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Dividend rate   0.00% 0.00% 0.00%  
Performance RSUs          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Granted (in shares) | shares   1,600,373      
Award vesting rights, percentage   100.00%      
Earned (in shares) | shares   2,028,355      
Unvested RSUs and PRSUs          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Total stock-based compensation expense   $ 242,100,000 $ 199,100,000 $ 161,800,000  
Unrecognized compensation cost related to stock awards, weighted-average period   2 years 8 months 12 days      
Granted (in shares) | shares   17,173,968      
Aggregate fair value of awards vested during the period   $ 322,200,000 183,400,000 164,100,000  
Unrecognized employee compensation cost   503,200,000      
Unvested restricted stock          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Total stock-based compensation expense   $ 1,800,000 9,300,000 24,600,000  
Unrecognized compensation cost related to stock awards, weighted-average period   1 month 6 days      
Aggregate fair value of awards vested during the period   $ 10,400,000 18,300,000 24,200,000  
Minimum | Performance RSUs          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Award vesting rights, percentage   0.00%      
Maximum | Performance RSUs          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Award vesting rights, percentage   150.00%      
Common stock          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Closing price of stock (in dollars per share) | $ / shares   $ 26.38      
2015 Equity Incentive Plan          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Equity awards of vest expire period   10 years      
2015 Equity Incentive Plan | Minimum          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Equity awards vesting period   2 years      
2015 Equity Incentive Plan | Maximum          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Equity awards vesting period   4 years      
2015 Equity Incentive Plan | Common stock          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Shares initially reserved for issuance (in shares) | shares   27,000,000      
Equity incentive plan, period in force   10 years      
Increase in shares reserved by percentage of capital stock   5.00%      
2015 Employee Stock Purchase Plan          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Shares reserved for future equity awards (in shares) | shares   5,000,000      
Employee stock purchase plan offering period   24 months      
Number of purchase periods | period   4      
Purchase period, term   6 months      
ESPP modification charge   $ 0 23,800,000 13,600,000  
Total stock-based compensation expense   35,400,000 25,800,000 $ 24,500,000  
Unrecognized stock-based compensation expense   $ 9,900,000      
Unrecognized compensation cost related to stock awards, weighted-average period   9 months 18 days      
2015 Employee Stock Purchase Plan | Common stock          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Increase in shares reserved by percentage of capital stock         1.00%
Shares reserved for future equity awards (in shares) | shares         3,500,000
Payroll deductions percentage   30.00%      
Share cap for ESPP at purchase date (in shares) | shares   3,000      
Dollar cap per purchase period $ 7,500        
Calendar year gap for ESPP contribution amount     $ 25,000    
Purchase price as percentage of fair market value of common stock   85.00%      
v3.22.1
Equity Incentive Plans - Equity Incentive Plans (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Options Outstanding, Number of Shares    
Beginning balance (in shares) 18,558,974  
Options exercised (in shares) (5,954,724)  
Options cancelled/forfeited (in shares) (335,312)  
Ending balance (in shares) 12,268,938 18,558,974
Vested and exercisable (in shares) 11,565,305  
Options Outstanding, Weighted- Average Exercise Price    
Beginning balance (in dollars per share) $ 9.60  
Options exercised (in dollars per share) 8.15  
Options cancelled/forfeited (in dollars per share) 11.50  
Ending balance (in dollars per share) 10.25 $ 9.60
Vested and exercisable (in dollars per share) $ 10.73  
Weighted- Average Remaining Contractual Life (Years)    
Weighted Average Remaining Contractual Life (Years) 3 years 6 months 4 years 3 months 18 days
Weighted Average Remaining Contractual Life (Years), Vested and exercisable 3 years 2 months 12 days  
Aggregate Intrinsic Value (in thousands)    
Aggregate Intrinsic Value $ 198,266 $ 251,503
Aggregate Intrinsic Value, Vested and exercisable $ 180,978  
v3.22.1
Equity Incentive Plans - Summary of Estimate Fair Values (Details) - $ / shares
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Employee Stock Options      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Expected term (in years)   5 years 7 months 24 days  
Expected volatility   52.07%  
Risk-free interest rate   0.30%  
Dividend rate   0.00%  
Fair value of common stock (in dollars per share)   $ 15.79  
Employee Stock Purchase Plan      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Expected volatility, minimum 44.00% 52.00% 42.00%
Expected volatility, maximum 61.00% 113.00% 47.00%
Risk-free interest rate, minimum 0.10% 0.10% 1.70%
Risk-free interest rate, maximum 0.20% 0.40% 2.50%
Dividend rate 0.00% 0.00% 0.00%
Employee Stock Purchase Plan | Minimum      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Expected term (in years) 6 months 6 months 6 months
Fair value of common stock (in dollars per share) $ 23.63 $ 9.07 $ 17.76
Employee Stock Purchase Plan | Maximum      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Expected term (in years) 2 years 2 years 2 years
Fair value of common stock (in dollars per share) $ 26.69 $ 15.26 $ 20.87
v3.22.1
Equity Incentive Plans - Restricted Stock Units (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Unvested RSUs and PRSUs    
Number of RSUs and PRSUs Outstanding    
Unvested, beginning balance (in shares) 30,830,082  
Granted (in shares) 17,173,968  
Vested (in shares) (12,955,468)  
Forfeited (in shares) (6,335,704)  
Unvested, ending balance (in shares) 28,712,878  
Weighted-Average Grant Date Fair Value    
Unvested, beginning balance (in dollars per share) $ 15.77  
Granted (in dollars per share) 23.42  
Vested (in dollars per share) 17.07  
Forfeited (in dollars per share) 16.60  
Unvested, ending balance (in dollars per share) $ 19.53  
Aggregate Intrinsic Value (in thousands) $ 757,446 $ 712,657
Unvested restricted stock    
Number of RSUs and PRSUs Outstanding    
Unvested, beginning balance (in shares) 557,836  
Vested (in shares) (440,687)  
Forfeited (in shares) (62,172)  
Unvested, ending balance (in shares) 54,977  
Weighted-Average Grant Date Fair Value    
Unvested, beginning balance (in dollars per share) $ 19.06  
Vested (in dollars per share) 18.78  
Forfeited (in dollars per share) 20.22  
Unvested, ending balance (in dollars per share) $ 20.02  
Aggregate Intrinsic Value (in thousands) $ 1,450 $ 12,903
v3.22.1
Equity Incentive Plans - Summary of Stock-Based Compensation Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense $ 286,963 $ 242,344 $ 226,705
Cost of revenue—product      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense 6,334 4,001 3,732
Cost of revenue—subscription services      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense 21,240 14,979 14,403
Research and development      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense 142,264 117,220 107,658
Sales and marketing      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense 71,439 65,248 67,560
General and administrative      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense $ 45,686 $ 40,896 $ 33,352
v3.22.1
Net Loss per Share Attributable to Common Stockholders - Net Loss per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Earnings Per Share [Abstract]      
Net loss $ (143,259) $ (282,076) $ (200,987)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 285,882 267,824 252,820
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 285,882 267,824 252,820
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.50) $ (1.05) $ (0.79)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.50) $ (1.05) $ (0.79)
v3.22.1
Net Loss per Share Attributable to Common Stockholders - Shares Excluded (Details) - shares
shares in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities (In shares) 72,440 80,337 81,218
Stock options to purchase common stock      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities (In shares) 15,686 23,180 31,315
Unvested RSUs and PRSUs      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities (In shares) 32,491 31,980 24,374
Unvested restricted stock      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities (In shares) 257 1,145 2,614
Shares related to convertible senior notes      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities (In shares) 21,884 21,884 21,884
Shares issuable pursuant to the ESPP      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities (In shares) 2,122 2,148 1,031
v3.22.1
Other Income (Expense), Net (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Other Income and Expenses [Abstract]      
Interest income $ 9,371 $ 17,442 $ 27,241
Interest expense (36,677) (31,403) (27,897)
Foreign currency transactions (losses) gains (5,235) 2,507 (3,396)
Other income 2,443 2,327 669
Total other income (expense), net $ (30,098) $ (9,127) $ (3,383)
v3.22.1
Income Taxes - Schedule of Geographical Breakdown of Income (Loss) before Provision for Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Income Tax Disclosure [Abstract]      
Domestic $ (192,058) $ (312,119) $ (212,672)
International 63,562 41,959 18,006
Loss before provision for income taxes $ (128,496) $ (270,160) $ (194,666)
v3.22.1
Income Taxes - Components of Provision for Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Current:      
State $ 592 $ 442 $ 538
Foreign 12,525 8,006 7,774
Total 13,117 8,448 8,312
Deferred:      
Federal 0 (218) (1,559)
State 0 0 (198)
Foreign 1,646 3,686 (234)
Total 1,646 3,468 (1,991)
Provision for income taxes $ 14,763 $ 11,916 $ 6,321
v3.22.1
Income Taxes - Reconciliation of the Federal Statutory Income Tax Rate and Effective Income Tax Rate (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Income Tax Disclosure [Abstract]      
Tax at federal statutory rate $ (26,984) $ (56,734) $ (40,880)
State tax, net of federal benefit 468 349 210
Stock-based compensation expense (19,658) (604) (6,683)
Research and development tax credits (16,783) (14,138) (11,033)
U.S. taxes on foreign income 25,059 14,021 0
Foreign rate differential (1,698) 2,282 2,935
Change in valuation allowance 48,270 63,146 61,050
Non-deductible expenses 4,381 0 0
Other 1,708 3,594 722
Provision for income taxes $ 14,763 $ 11,916 $ 6,321
v3.22.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Feb. 06, 2022
Jan. 31, 2021
Deferred tax assets:    
Net operating loss carryforwards $ 369,904 $ 308,250
Tax credit carryover 134,085 104,247
Accruals and reserves 22,625 22,263
Deferred revenue 66,242 69,886
Stock-based compensation expense 25,247 28,310
Depreciation and amortization 0 120
Charitable contribution carryforwards 290 229
Interest expense limitation (163(j)) 0 110
ASC 842 lease liabilities 28,577 33,302
Other 1,589 0
Total deferred tax assets 648,559 566,717
Valuation allowance (554,553) (484,437)
Total deferred tax assets, net of valuation allowance 94,006 82,280
Deferred tax liabilities:    
Depreciation and amortization (12,992) 0
Deferred commissions (53,219) (41,526)
Convertible debt (4,642) (8,147)
ASC 842 right-of-use assets (24,608) (29,183)
Acquired intangibles and goodwill (6,850) (8,727)
Intercompany interest (874) 0
Other 0 (2,230)
Total deferred tax liabilities (103,185) (89,813)
Net deferred tax liabilities $ (9,179) $ (7,533)
v3.22.1
Income Taxes - Additional Information (Details) - USD ($)
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Jan. 31, 2019
Operating Loss Carryforwards [Line Items]        
Undistributed earnings of foreign subsidiaries $ 134,200,000      
Deferred tax assets, increase (decrease) in valuation allowance 70,100,000 $ 98,600,000    
Gross unrecognized tax benefit 51,582,000 $ 39,571,000 $ 28,570,000 $ 18,891,000
Unrecognized tax benefits that would impact effective tax rate 3,500,000      
Current or cumulative interest and penalties related to uncertain tax positions 0      
Federal        
Operating Loss Carryforwards [Line Items]        
Net operating loss carryforwards 1,500,000,000      
Research and development tax credit carryforwards 98,700,000      
State        
Operating Loss Carryforwards [Line Items]        
Net operating loss carryforwards 858,700,000      
Research and development tax credit carryforwards $ 88,000,000      
v3.22.1
Income Taxes - Activity Related to Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Reconciliation of Unrecognized Tax Benefits      
Gross unrecognized tax benefits—beginning balance $ 39,571 $ 28,570 $ 18,891
Decreases related to tax positions taken during prior years (173) (345) (34)
Increases related to tax positions taken during prior years 1,201 1,881 408
Increases related to tax positions taken during current year 10,983 9,465 9,305
Gross unrecognized tax benefits—ending balance $ 51,582 $ 39,571 $ 28,570
v3.22.1
Segment Information - Revenue by Geographic Area (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Revenues From External Customers And Long Lived Assets [Line Items]      
Total revenue $ 2,180,848 $ 1,684,179 $ 1,643,440
United States      
Revenues From External Customers And Long Lived Assets [Line Items]      
Total revenue 1,580,022 1,195,428 1,184,923
Rest of the world      
Revenues From External Customers And Long Lived Assets [Line Items]      
Total revenue $ 600,826 $ 488,751 $ 458,517
v3.22.1
Segment Information - Long-Lived Assets by Geographic Area (Details) - USD ($)
$ in Thousands
Feb. 06, 2022
Jan. 31, 2021
Revenues From External Customers And Long Lived Assets [Line Items]    
Property and equipment, net $ 195,282 $ 163,041
United States    
Revenues From External Customers And Long Lived Assets [Line Items]    
Property and equipment, net 187,228 152,859
Rest of the world    
Revenues From External Customers And Long Lived Assets [Line Items]    
Property and equipment, net $ 8,054 $ 10,182
v3.22.1
401(k) Plan - Additional Information (Details) - USD ($)
12 Months Ended
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Compensation Related Costs [Abstract]      
Maximum annual contributions per employee (as a percent) 85.00%    
Company match of employee contributions (percent) 50.00%    
Maximum annual employer contribution, per employee $ 4,000    
Company contributions to the plan $ 11,100,000 $ 10,200,000 $ 8,600,000